Hypermobility syndrome

M13_HYPERMOBILITY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M35.7 Cause of death: ICD-10 — M35.7 2 out of 7 registries used, show all original rules.	2463
4. Check minimum number of events None	2463
5. Include endpoints None	2463
6. Filter based on genotype QC (FinnGen only)	2277

Control definitions (FinnGen only)

Control exclude: M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M35
Name in latin: Syndroma hypermobilitatis

NAME	M13_HYPERMOBILITY
CONTROL_EXCLUDE	M13_SYSTCONNECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M357
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M357
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypermobility syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	12843	11010	1784
Only index persons	12485	10796	1689
Unadjusted period prevalence (%)
Whole population	0.28	0.32	0.05
Only index persons	0.35	0.40	0.06
Median age at first event (years)
Whole population	34.47	36.00	25.00
Only index persons	34.85	36.20	26.18

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2277	2127	150
Unadjusted period prevalence (%)	0.71	0.76	0.07
Median age at first event (years)	38.27	38.29	38.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2341: Matched controls
23410

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M35.7

ICD-10 Finland

Hypermobility syndrome

4503599627370496.0

307.7

2339

M79.0

ICD-10 Finland

Rheumatism, unspecified

13.0

307.7

366

329

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

114.0

307.7

236

M79.7

ICD-10 Finland

Fibromyalgia

11.0

307.7

464

515

N06AX21

ATC

duloxetine; oral

5.4

291.5

753

1894

M25.5

ICD-10 Finland

Pain in joint

4.6

287.6

1490

6404

N03AX16

ATC

[U] pregabalin

4.6

264.6

923

2927

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.1

239.2

482

958

N03AX12

ATC

[U] gabapentin; oral

4.6

225.9

696

1979

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

5.4

196.2

447

984

N02AX02

ATC

tramadol; systemic, rectal

3.4

181.2

1261

6029

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

39.8

179.9

110

P01BA02

ATC

hydroxychloroquine; oral

5.4

174.8

391

843

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

5.3

171.5

387

840

M54.5

ICD-10 Finland

Low back pain

3.2

165.6

1366

7102

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

10.7

163.1

183

184

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.4

152.8

449

1203

A01

ICPC

Pain general/multiple sites

4.2

148.8

464

1298

L28

ICPC

Limited function/disability (L)

3.8

143.1

539

1719

M01AH01

ATC

celecoxib; oral

3.6

137.4

567

1917

M54.4

ICD-10 Finland

Lumbago with sciatica

3.2

137.1

753

3033

L04AX03

ATC

methotrexate; systemic

4.2

135.3

422

1176

R4120

NOMESCO Finland

Occupational therapy

5.0

133.4

316

709

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.9

133.4

454

1346

H02AB06

ATC

prednisolone; systemic

2.9

132.3

1358

7637

N06AX16

ATC

venlafaxine; oral

3.1

121.7

674

2704

N06AA09

ATC

amitriptyline; systemic

4.3

121.3

352

926

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

7.7

119.2

174

243

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.7

118.3

1320

7594

R51.80

ICD-10 Finland

Headache

2.9

116.1

746

3238

M79.6

ICD-10 Finland

Pain in limb

2.7

115.1

1401

8372

M79.1

ICD-10 Finland

Myalgia

3.0

114.7

683

2842

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

114.1

793

3583

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.6

113.3

1267

7246

A07EC01

ATC

sulfasalazine; oral, rectal

4.1

113.2

349

958

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.0

110.5

361

1032

A02BC02

ATC

pantoprazole; systemic

2.9

108.2

1770

12085

M03BC01

ATC

orphenadrine (citrate); systemic

2.7

107.4

843

4033

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.1

101.0

534

2063

M01AH05

ATC

etoricoxib; oral

2.8

101.0

1746

12036

G54.0

ICD-10 Finland

Brachial plexus disorders

5.6

100.8

202

389

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.1

99.9

501

1876

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.4

96.8

266

667

M70.6

ICD-10 Finland

Trochanteric bursitis

3.1

95.3

476

1775

G44.2

ICD-10 Finland

Tension-type headache

2.8

94.1

614

2647

M54.6

ICD-10 Finland

Pain in thoracic spine

3.5

92.3

366

1185

R52.2

ICD-10 Finland

Other chronic pain

5.1

91.3

204

432

UJF32

NOMESCO Finland

Coloscopy

2.7

89.4

630

2817

L20

ICPC

Joint symptom/complaint NOS

4.8

88.7

214

483

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.0

87.2

267

724

M01AC06

ATC

meloxicam; systemic, rectal

2.4

87.1

953

5220

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

87.0

768

3820

R52.9

ICD-10 Finland

Pain, unspecified

3.2

86.5

398

1409

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.0

86.2

450

1713

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.0

85.7

264

719

M54.2

ICD-10 Finland

Cervicalgia

3.3

84.4

355

1189

ZYC01

NOMESCO Finland

Remote contact by phone

3.7

84.3

289

848

M03BX02

ATC

tizanidine; oral

2.5

83.1

1755

12658

R4110

NOMESCO Finland

Physiotherapy

2.5

82.5

754

3794

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

8.4

81.9

109

136

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

81.5

625

2896

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

79.1

279

833

R06.0

ICD-10 Finland

Dyspnoea

2.5

79.1

708

3519

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.7

78.5

523

2257

ZX140

NOMESCO Finland

Intra articular

13.4

77.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

77.7

593

2733

A02BC05

ATC

esomeprazole; systemic

2.2

77.6

1080

6466

L03

ICPC

Low back symptom/complaint

2.3

77.5

982

5659

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

76.9

485

2033

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

75.7

705

3556

R03AC02

ATC

salbutamol; inhalant

2.3

74.5

1606

11397

L88

ICPC

Rheumatoid/seropositive arthritis

4.7

74.3

182

415

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.1

74.1

349

1246

SPAT1229

SPAT

Assessment of need for aid

4.3

73.4

198

487

N02BF01

ATC

gabapentin; oral

3.0

73.3

369

1368

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

72.9

673

3373

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

5.6

72.5

141

263

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.9

72.4

229

633

M45

ICD-10 Finland

Ankylosing spondylitis

6.7

72.4

118

185

N06AX11

ATC

mirtazapine; oral

2.2

71.9

1000

5938

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

113.7

71.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

70.5

428

1753

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.1

69.3

327

1166

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.1

69.2

323

1145

Z50.1

ICD-10 Finland

Other physical therapy

4.3

68.9

187

462

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

68.4

389

1538

M13.9

ICD-10 Finland

Arthritis, unspecified

3.3

67.8

278

911

M01AB05

ATC

diclofenac; systemic, rectal

2.3

67.5

1677

12354

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

67.3

965

5760

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.9

67.2

155

336

N02BF02

ATC

pregabalin; oral

3.3

66.8

274

898

M01AE02

ATC

naproxen; oral, rectal

2.2

66.2

1639

12007

R20.2

ICD-10 Finland

Paraesthesia of skin

3.1

66.2

315

1128

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.6

65.9

164

378

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

65.6

871

5034

K07.60

ICD-10 Finland

Snapping jaw

3.1

65.6

299

1044

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.4

65.4

555

2662

R03DC03

ATC

montelukast; oral

2.4

64.7

596

2963

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

64.6

624

3165

Z71.8

ICD-10 Finland

Other specified counselling

2.1

64.4

1119

7146

M50.3

ICD-10 Finland

Other cervical disc degeneration

6.3

64.4

111

184

L17

ICPC

Foot/toe symptom/complaint

2.1

64.3

871

5064

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

64.3

665

3471

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.7

63.9

154

346

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

63.8

385

1566

N05AH04

ATC

quetiapine; oral

2.3

62.9

632

3255

M24.2

ICD-10 Finland

Disorder of ligament

6.8

61.8

149

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

61.0

963

5903

Z31.5

ICD-10 Finland

Genetic counselling

3.0

60.8

297

1077

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.3

60.6

554

2735

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.3

60.6

162

395

R02

ICPC

Shortness of breath/dyspnoea

2.6

59.7

391

1655

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

5.9

59.6

110

195

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

59.4

798

4597

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

58.8

1175

7810

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.1

58.6

264

913

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.2

58.2

649

3472

L29

ICPC

Musculoskeletal sympt/complt other

2.9

57.6

309

1178

N03AX09

ATC

lamotrigine; oral

3.1

57.4

256

880

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

57.3

304

1152

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.1

57.1

260

904

R42

ICD-10 Finland

Dizziness and giddiness

2.3

56.9

579

2981

M02AA07

ATC

piroxicam; topical

2.1

56.9

773

4458

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.1

56.6

123

253

N06AA10

ATC

nortriptyline; systemic

5.4

56.5

113

216

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

56.2

310

1199

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.2

55.9

154

384

C07AB07

ATC

bisoprolol; oral

2.0

55.7

848

5090

A02BC03

ATC

lansoprazole; oral

2.1

55.0

657

3599

XA402

NOMESCO Finland

ENMG

5.5

54.9

109

207

TEA00

NOMESCO Finland

Biopsy of lip

12.5

54.8

WZC30

NOMESCO Finland

Teaching

2.4

54.6

426

1952

M25.2

ICD-10 Finland

Flail joint

6.6

54.3

140

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

54.0

694

3906

R06AE07

ATC

cetirizine; oral

2.0

53.9

1320

9305

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

53.4

958

6073

M53.2

ICD-10 Finland

Spinal instabilities

10.2

53.2

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

53.1

509

2548

M35.3

ICD-10 Finland

Polymyalgia rheumatica

9.9

52.9

N02BE01

ATC

paracetamol; systemic, rectal

3.4

52.8

2179

18729

K30

ICD-10 Finland

Functional dyspepsia

2.4

52.5

406

1851

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

52.0

640

3536

C07AA05

ATC

propranolol; systemic

2.1

51.9

693

3946

M01AX17

ATC

nimesulide; oral

2.3

51.9

486

2408

L15

ICPC

Knee symptom/complaint

2.1

51.9

709

4073

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

6.9

51.5

119

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

8.3

51.4

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.5

51.2

186

562

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

51.0

527

2716

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

50.5

935

5961

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

50.3

432

2060

N02AA05

ATC

oxycodone; systemic

2.6

50.2

317

1311

M01AB08

ATC

etodolac; oral

3.2

50.2

215

720

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

50.2

849

5248

G43.3

ICD-10 Finland

Complicated migraine

4.2

49.9

139

349

J01AA02

ATC

doxycycline; systemic

2.1

49.8

1838

14742

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

49.7

350

1525

L01BA01

ATC

methotrexate; systemic

4.2

49.5

136

338

3007

Kela drug reimbursment

Erenumab and fremanezumab

4.7

49.3

117

259

L01

ICPC

Neck symptom/complaint

2.1

49.3

579

3134

L02

ICPC

Back symptom/complaint

2.4

49.1

409

1923

R4110, ,

SPAT

2.5

49.0

370

1665

N05BA04

ATC

oxazepam; oral

2.0

49.0

751

4479

R53

ICD-10 Finland

Malaise and fatigue

2.0

48.9

781

4723

G47.3

ICD-10 Finland

Sleep apnoea

2.2

48.8

520

2708

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.9

48.1

242

888

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

48.1

381

1751

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

47.3

564

3064

H02AB07

ATC

prednisone; oral

2.5

47.2

340

1495

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

47.0

309

1301

Z3226

NOMESCO Finland

Physiotherapist

2.2

47.0

463

2333

R03BA05

ATC

fluticasone; inhalant

2.1

47.0

559

3034

C01CA24

ATC

epinephrine; parenteral

2.7

46.9

284

1148

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.6

46.7

160

465

M01AH02

ATC

rofecoxib; oral

2.8

46.6

263

1026

L99

ICPC

Musculoskeletal disease other

5.0

46.6

103

215

L12

ICPC

Hand/finger symptom/complaint

2.1

46.5

564

3082

A02BA02

ATC

ranitidine; systemic

2.3

46.0

399

1905

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

46.0

247

938

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

46.0

306

1296

N06AX12

ATC

bupropion; oral

2.5

45.8

340

1515

N06AB04

ATC

citalopram; systemic

2.1

45.6

576

3192

R96

ICPC

Asthma

2.5

45.4

310

1329

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.2

45.2

193

644

M22.4

ICD-10 Finland

Chondromalacia patellae

3.6

45.2

154

446

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

45.1

369

1717

ZY010

NOMESCO Finland

Hospital outpatient

2.8

44.9

242

921

A02BC01

ATC

omeprazole; systemic

2.0

44.7

658

3847

P01AB01

ATC

metronidazole; oral, rectal

1.8

44.7

1127

7844

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

44.4

416

2049

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

5.2

44.4

185

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

44.3

597

3382

N03AE01

ATC

clonazepam; systemic

3.3

44.1

173

548

G50.1

ICD-10 Finland

Atypical facial pain

5.3

43.9

172

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

5.2

43.6

177

F34.1

ICD-10 Finland

Dysthymia

3.3

43.5

172

548

L16

ICPC

Ankle symptom/complaint

2.2

43.4

423

2116

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

5.4

43.4

163

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.7

43.1

106

L04AA13

ATC

[U] leflunomide

4.7

42.9

100

218

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.3

42.8

172

553

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

42.7

301

1307

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

42.4

505

2729

L13

ICPC

Hip symptom/complaint

2.1

42.3

464

2430

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

42.3

1125

7915

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.9

42.0

202

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.7

41.9

244

965

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.8

41.4

229

882

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

41.3

365

1751

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.4

41.3

328

1503

M54.8

ICD-10 Finland

Other dorsalgia

3.1

41.1

187

647

R5110, ,

SPAT

2.9

41.0

200

720

L08

ICPC

Shoulder symptom/complaint

2.0

40.8

593

3435

ZX120

NOMESCO Finland

Intravenous

2.7

40.8

240

954

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.1

40.6

178

603

WZC30, ,

SPAT

2.7

40.6

245

987

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.4

40.5

304

1358

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

40.5

942

6342

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.5

40.0

145

437

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.2

39.9

166

545

M54.3

ICD-10 Finland

Sciatica

3.0

39.9

192

686

XKD00

NOMESCO Finland

Uroflowmetry

3.4

39.8

147

448

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

5.6

39.8

139

AA1AD

NOMESCO Finland

CT of head and brain

2.0

39.8

507

2802

ZXH09, ,

SPAT

3.9

39.7

122

329

R52.1

ICD-10 Finland

Chronic intractable pain

7.5

39.5

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.0

39.3

184

647

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.5

39.3

230

SPAT1240

SPAT

Therapeutic discussion

2.1

39.3

434

2274

R01AD09

ATC

mometasone; nasal

1.8

39.2

1316

9828

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

5.6

39.0

138

T78.4

ICD-10 Finland

Allergy, unspecified

2.8

38.8

209

793

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

5.0

38.8

172

M48.0

ICD-10 Finland

Spinal stenosis

2.8

38.7

205

771

C09CA06

ATC

candesartan; oral

1.9

38.7

577

3365

G93.3

ICD-10 Finland

Postviral fatigue syndrome

7.4

38.6

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.5

38.6

139

417

J01FA10

ATC

azithromycin; systemic

1.8

38.3

1638

13093

M54.1

ICD-10 Finland

Radiculopathy

3.4

38.3

144

444

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

5.3

38.2

148

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.6

38.2

249

1040

Z3231

NOMESCO Finland

Registered nurse

1.9

38.1

633

3822

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

38.0

391

1990

N06AX22

ATC

agomelatine; oral

3.7

37.7

125

355

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.0

37.6

110

286

N06AB03

ATC

fluoxetine; oral

2.2

37.6

384

1949

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.1

37.6

105

264

J01FF01

ATC

clindamycin; systemic

1.9

37.5

650

3976

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

7.0

37.4

N06AB10

ATC

escitalopram; oral

1.8

37.3

713

4495

J01FA06

ATC

roxithromycin; oral

1.8

37.3

960

6612

M22.0

ICD-10 Finland

Recurrent dislocation of patella

4.7

37.3

194

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

37.1

213

835

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

5.3

37.0

145

N03AX11

ATC

topiramate; oral

3.5

36.9

134

404

R4120, ,

SPAT

6.5

36.7

M03BX01

ATC

baclofen; systemic

4.9

36.6

169

N06BA04

ATC

methylphenidate; oral

2.7

36.6

211

829

R03AC03

ATC

terbutaline; inhalant

2.1

36.6

408

2140

N05BA01

ATC

diazepam; systemic, rectal

2.3

36.5

320

1525

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.2

36.2

147

475

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.5

36.2

129

384

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

36.2

333

1619

XF404

NOMESCO Finland

Ambulatory ECG

2.9

36.1

179

649

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.1

36.1

160

545

L04AB04

ATC

adalimumab; parenteral

3.8

36.0

115

318

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.0

36.0

171

606

G44.0

ICD-10 Finland

Cluster headache syndrome

5.6

35.7

124

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.0

35.6

169

598

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

35.5

396

2075

M43.1

ICD-10 Finland

Spondylolisthesis

3.5

35.4

125

370

M54

ICD-10 Finland

Dorsalgia

2.0

35.3

424

2283

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.6

35.3

226

935

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

4.6

35.2

191

R11

ICD-10 Finland

Nausea and vomiting

2.3

35.1

295

1380

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

35.1

587

3539

ZXA05

NOMESCO Finland

Left side

2.0

35.1

453

2504

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

35.0

480

2710

C08DA01

ATC

verapamil; systemic

3.8

34.7

107

289

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

34.6

430

2343

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.4

34.5

271

1231

R03BA01

ATC

beclometasone; inhalant

2.1

34.3

363

1864

M79.8

ICD-10 Finland

Other specified soft tissue disorders

8.1

34.1

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.2

34.0

144

477

UKC02

NOMESCO Finland

Cystoscopy

2.5

34.0

225

945

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

33.9

474

2689

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

6.1

33.8

XQ800

NOMESCO Finland

Prick test

2.3

33.7

291

1376

X58

ICD-10 Finland

Exposure to other specified factors

2.0

33.7

428

2348

R00.2

ICD-10 Finland

Palpitations

2.3

33.7

295

1403

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

33.7

366

1897

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

33.6

270

1238

M01AX05

ATC

glucosamine; oral

2.3

33.4

283

1327

Z2445

NOMESCO Finland

Psychologist

2.9

33.4

167

608

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.1

33.1

371

1945

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.8

33.1

108

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.4

33.0

124

382

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

33.0

433

2403

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.6

32.9

207

849

R03BA02

ATC

budesonide; inhalant

1.9

32.8

504

2948

R06AX22

ATC

ebastine; oral

1.9

32.7

532

3169

J01EA01

ATC

trimethoprim; systemic

1.8

32.5

712

4640

S18

ICPC

Laceration/cut

1.7

32.4

988

7056

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.7

32.4

104

289

N02CD03

ATC

fremanezumab; systemic

4.5

32.3

179

L04AX01

ATC

azathioprine; systemic

3.2

32.3

129

413

L04AB01

ATC

etanercept; parenteral

4.4

32.2

192

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.7

32.1

164

D01

ICPC

Abdominal pain/cramps general

2.0

31.8

434

2438

J02AC01

ATC

fluconazole; systemic

1.7

31.8

1222

9255

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.1

31.8

140

475

UJF92

NOMESCO Finland

Capsular endoscopy

4.2

31.5

208

XA800

NOMESCO Finland

Neuropsychological investigation

3.1

31.5

134

445

N04BC05

ATC

pramipexole; oral

2.7

31.4

172

657

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.6

31.4

104

295

J01MA02

ATC

ciprofloxacin; systemic

1.7

31.3

768

5158

J01FA09

ATC

clarithromycin; systemic

1.7

31.3

829

5686

ZXA00

NOMESCO Finland

Right side

1.9

31.2

476

2772

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.9

31.2

245

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

31.2

257

1190

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

31.2

284

1371

M89.0

ICD-10 Finland

Algoneurodystrophy

6.1

31.1

A28

ICPC

Limited function/disability NOS

2.4

31.1

238

1068

WZA10

NOMESCO Finland

Extensive medical or dental certificate

5.2

30.9

126

J45

ICD-10 Finland

Asthma

2.1

30.9

328

1681

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

30.9

1925

16573

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

30.9

613

3873

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.2

30.8

290

1419

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

30.7

343

1793

ZY010, ,

SPAT

5.2

30.5

124

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.6

30.5

182

727

B01AB05

ATC

enoxaparin; parenteral

1.8

30.4

630

4027

R50.9

ICD-10 Finland

Fever, unspecified

2.0

30.4

389

2135

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

30.3

1855

15816

R1250

NOMESCO Finland

Evaluation of functional capability

4.1

30.2

206

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

30.2

612

3888

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

30.1

124

404

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.3

30.1

117

368

M01AX01

ATC

nabumetone; oral

3.6

30.1

101

289

H02AB04

ATC

methylprednisolone; systemic

2.1

30.1

337

1762

R03BB04

ATC

tiotropium bromide; inhalant

2.7

30.1

166

637

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

30.0

637

4098

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

30.0

1250

9609

D06

ICPC

Abdominal pain localized other

2.1

29.9

312

1588

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

29.8

837

5815

R05

ICPC

Cough

1.7

29.6

703

4667

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

29.4

178

715

WX002

NOMESCO Finland

Sedation and analgesia

2.0

29.4

377

2068

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.7

29.2

169

664

A02BC04

ATC

rabeprazole; oral

2.2

29.2

259

1236

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

29.1

1040

7671

N06AX26

ATC

vortioxetine; oral

2.1

29.0

293

1472

A04

ICPC

Weakness/tiredness general

1.9

28.9

472

2803

R07.3

ICD-10 Finland

Other chest pain

2.2

28.9

258

1235

C10AC01

ATC

colestyramine; oral

3.6

28.8

269

ZYC01, ,

SPAT

2.0

28.7

369

2024

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.7

28.7

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.4

28.6

218

975

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

28.6

267

1301

F45.8

ICD-10 Finland

Other somatoform disorders

2.1

28.6

303

1551

H57.1

ICD-10 Finland

Ocular pain

2.7

28.5

159

613

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.3

28.5

109

N89

ICPC

Migraine

2.4

28.5

215

958

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.6

28.4

170

679

Z01.2

ICD-10 Finland

Dental examination

1.6

28.4

1319

10354

L86

ICPC

Back syndrome with radiating pain

2.5

28.4

184

764

M01AB55

ATC

diclofenac, combinations; oral

2.9

28.3

135

479

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

28.1

407

2323

Z2446

NOMESCO Finland

Social worker

2.4

28.0

195

838

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.6

27.9

172

697

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

5.7

27.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

27.9

210

934

N02AJ13

ATC

tramadol and paracetamol; systemic

4.1

27.9

192

N05CF01

ATC

zopiclone; oral

1.7

27.8

646

4248

M53.8

ICD-10 Finland

Other specified dorsopathies

6.7

27.7

Z01.9

ICD-10 Finland

Special examination, unspecified

2.6

27.7

166

664

R06.4

ICD-10 Finland

Hyperventilation

4.4

27.5

164

J01DA01

ATC

[U] cefalexin

1.6

27.4

1460

11805

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.2

27.4

110

353

G43

ICD-10 Finland

Migraine

2.1

27.4

288

1468

R51

ICD-10 Finland

Headache

2.3

27.4

229

1066

Z00.0

ICD-10 Finland

General medical examination

1.8

27.3

480

2910

R51.81

ICD-10 Finland

Facial pain NOS

3.4

27.3

298

N06AB06

ATC

sertraline; oral

1.9

27.3

392

2230

F45.0

ICD-10 Finland

Somatization disorder

8.8

27.2

P01

ICPC

Feeling anxious/nervous/tense

1.7

27.1

579

3716

R01AD58

ATC

fluticasone, combinations; nasal

1.6

27.1

829

5853

A06AD11

ATC

lactulose; oral

2.2

27.1

236

1117

SPAT1216

SPAT

Assessment of functional ability

2.2

27.0

252

1226

D07AD01

ATC

clobetasol; topical

1.9

26.8

403

2327

R39.1

ICD-10 Finland

Other difficulties with micturition

4.5

26.7

147

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.9

26.6

130

467

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

26.6

133

484

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.0

26.6

190

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.9

26.5

128

457

P03

ICPC

Feeling depressed

1.9

26.4

423

2490

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.2

26.3

174

P06

ICPC

Sleep disturbance

1.9

26.2

405

2356

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

5.2

26.0

103

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.3

25.9

211

970

ZXH06, ,

SPAT

2.7

25.8

145

561

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

25.7

997

7430

S83.0

ICD-10 Finland

Dislocation of patella

3.2

25.7

102

325

N02CD01

ATC

erenumab; parenteral

4.3

25.6

156

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.0

25.6

115

394

K02.1

ICD-10 Finland

Caries of dentine

1.6

25.6

1593

13261

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

25.6

349

1948

SPAT1301

SPAT

No procedures

1.7

25.5

679

4611

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.7

25.5

128

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.7

25.5

233

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

5.4

25.5

N02CC07

ATC

frovatriptan; oral

2.3

25.2

204

935

XG466

NOMESCO Finland

Sleep oxymetry

4.1

25.2

171

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.5

25.2

254

M01AH03

ATC

valdecoxib; oral

2.8

25.1

133

499

NF1AA

NOMESCO Finland

Hip X-ray examination

2.7

25.1

145

569

SFA10

NOMESCO Finland

One-surface restoration

1.6

25.1

1460

11932

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

24.9

168

711

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

24.8

212

994

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

70.7

24.8

IHZ05, ,

SPAT

2.2

24.6

216

1025

Z08

ICPC

Social welfare problem

4.6

24.6

132

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.6

24.6

234

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

24.3

258

1317

R74

ICPC

Upper respiratory infection acute

1.6

24.3

1123

8679

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

24.3

202

937

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

24.2

925

6841

C03CA01

ATC

furosemide; systemic

2.0

24.2

310

1693

N02CC06

ATC

eletriptan; oral

2.4

24.2

168

720

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

24.1

150

610

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.0

24.1

177

M02AA10

ATC

ketoprofen; topical

1.9

24.0

331

1852

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

24.0

163

692

H03AA01

ATC

levothyroxine sodium; systemic

1.7

23.7

592

3942

R01AD05

ATC

budesonide; nasal

2.2

23.7

214

1026

N02CC03

ATC

zolmitriptan; nasal, oral

2.1

23.7

228

1122

M05BA04

ATC

alendronic acid; oral

2.8

23.6

123

458

H02AB09

ATC

hydrocortisone; systemic

3.6

23.4

227

E0000UV, ,

ATC

1.6

23.4

1049

8027

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

23.4

1603

13491

R01AD08

ATC

fluticasone; nasal

1.6

23.4

769

5481

J01DB01

ATC

cefalexin; oral

1.8

23.3

1973

17523

L04AB06

ATC

golimumab; parenteral

5.1

23.3

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.3

23.3

142

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

23.2

161

689

M01AE52

ATC

naproxen and esomeprazole; oral

3.2

23.2

298

N01

ICPC

Headache

1.8

23.2

451

2805

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

8.4

23.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

23.1

198

929

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

23.0

466

2930

M77.4

ICD-10 Finland

Metatarsalgia

2.2

23.0

207

992

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.1

22.9

161

R03BA08

ATC

ciclesonide; inhalant

2.1

22.9

247

1268

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.9

22.9

112

403

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

22.9

695

4856

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.7

22.7

116

P76

ICPC

Depressive disorder

2.0

22.7

274

1465

S06.0

ICD-10 Finland

Concussion

2.0

22.7

278

1494

G43.8

ICD-10 Finland

Other migraine

3.1

22.6

308

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

22.6

387

2317

WZC00, ,

SPAT

1.8

22.6

404

2450

P29

ICPC

Psychological sympt/compl other

1.9

22.6

318

1791

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

22.6

196

925

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

22.6

199

945

C07AB02

ATC

metoprolol; systemic

2.0

22.5

282

1526

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.3

22.5

268

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

22.4

574

3840

R06AX27

ATC

desloratadine; oral

1.6

22.4

890

6612

SPAT1058

SPAT

PEF monitoring instruction

2.3

22.3

185

856

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.4

22.3

N81.6

ICD-10 Finland

Rectocele

2.3

22.3

174

785

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

22.3

1071

8294

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

22.3

129

507

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

22.2

258

1360

S29

ICPC

Skin symptom/complaint other

1.7

22.2

487

3128

R5599

NOMESCO Finland

Other rehabilitation service

3.3

22.1

271

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.9

22.1

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

6.1

22.0

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

22.0

1382

11325

K08.80

ICD-10 Finland

Toothache NOS

1.9

21.9

309

1740

R05

ICD-10 Finland

Cough

1.7

21.9

534

3526

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.8

21.8

176

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.9

21.7

163

I73.0

ICD-10 Finland

Raynaud syndrome

3.7

21.7

186

A04AA01

ATC

ondansetron; systemic, rectal

2.2

21.7

197

947

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

21.6

721

5135

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

21.6

486

3139

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

4.9

21.6

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.6

21.6

133

539

N06AX03

ATC

mianserin; oral

2.7

21.5

117

445

L11

ICPC

Wrist symptom/complaint

1.9

21.4

313

1782

XCK00

NOMESCO Finland

Perimetry

2.7

21.4

115

435

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.2

21.3

139

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.3

21.2

247

A03FA02

ATC

cisapride; oral, rectal

2.5

21.2

143

604

M22.1

ICD-10 Finland

Recurrent subluxation of patella

6.0

21.2

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

21.1

150

649

R25.2

ICD-10 Finland

Cramp and spasm

3.4

21.1

233

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

21.0

229

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.0

20.9

227

1167

SPAT1284

SPAT

Extensive health certificate

2.9

20.8

340

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

20.7

146

630

N03AG01

ATC

valproic acid; systemic, rectal

2.3

20.7

162

732

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

20.7

259

1401

M23.8

ICD-10 Finland

Other internal derangements of knee

2.6

20.7

124

496

J01MA12

ATC

levofloxacin; systemic

1.8

20.6

319

1849

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

20.6

130

533

M23.5

ICD-10 Finland

Chronic instability of knee

6.4

20.6

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.8

20.5

106

393

J46

ICD-10 Finland

Status asthmaticus

3.0

20.5

305

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.6

20.4

117

457

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

20.4

165

755

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

20.4

150

659

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

20.4

137

578

N02CC04

ATC

rizatriptan; oral

2.0

20.4

228

1185

N30.0

ICD-10 Finland

Acute cystitis

1.7

20.4

499

3290

M15

ICD-10 Finland

Polyarthrosis

2.7

20.3

108

406

F84.5

ICD-10 Finland

Asperger syndrome

5.3

20.3

S03.0

ICD-10 Finland

Dislocation of jaw

5.8

20.2

M77.1

ICD-10 Finland

Lateral epicondylitis

1.9

20.2

264

1447

TAB00

NOMESCO Finland

Lumbar puncture

2.5

20.2

134

562

IGY02, ,

SPAT

3.5

20.2

210

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

20.0

596

4122

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.5

20.0

197

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

19.9

724

5240

L40.5

ICD-10 Finland

Arthropathic psoriasis

4.0

19.9

142

WX722

NOMESCO Finland

PEEP

3.1

19.9

268

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

19.8

1314

10784

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.4

19.6

209

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

19.6

108

414

SPAT1202

SPAT

Intra-articular injection

4.0

19.5

144

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

5.7

19.5

R06.5

ICD-10 Finland

Mouth breathing

2.1

19.4

198

994

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

19.4

637

4501

XF402

NOMESCO Finland

ECG with work load test

2.3

19.4

145

642

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

19.2

254

1397

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

4.4

19.2

111

OAA68, ,

SPAT

3.3

19.2

217

SPAT1310

SPAT

Counselling related to known health issue

1.5

19.2

736

5382

S43.0

ICD-10 Finland

Dislocation of shoulder joint

2.9

19.1

317

UJD02

NOMESCO Finland

Gastroscopy

2.8

19.1

100

373

SPAT1325

SPAT

Vaccination

1.6

19.1

647

4601

M25.3

ICD-10 Finland

Other instability of joint

7.6

19.1

J45.8

ICD-10 Finland

Mixed asthma

3.0

19.1

285

N05CF02

ATC

zolpidem; oral

1.7

19.0

419

2682

L18

ICPC

Muscle pain

2.5

19.0

125

522

G04BD12

ATC

mirabegron; oral

2.1

19.0

179

872

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.9

19.0

147

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

19.0

549

3764

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

18.9

225

1194

R60.0

ICD-10 Finland

Localized oedema

2.0

18.9

235

1266

N02CD02

ATC

galcanezumab; parenteral

5.3

18.9

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.3

18.8

113

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

18.8

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.8

18.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

18.7

141

627

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

7.1

18.7

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

18.6

247

1360

K80

ICPC

Cardiac arrhythmia NOS

2.1

18.6

189

948

L50.9

ICD-10 Finland

Urticaria, unspecified

2.3

18.5

141

629

SPAT1153

SPAT

Removal of sutures

1.6

18.5

546

3757

A29

ICPC

General symptom/complaint other

1.8

18.5

293

1707

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.3

18.5

142

636

N02CC05

ATC

almotriptan; oral

2.2

18.5

164

780

N03AF01

ATC

carbamazepine; oral, rectal

2.6

18.4

108

427

N06BA12

ATC

lisdexamfetamine; oral

3.2

18.4

238

R06AX13

ATC

loratadine; oral

1.6

18.4

445

2916

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

3.1

18.4

254

SBB10

NOMESCO Finland

Dental impressions

1.9

18.4

232

1257

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

18.4

232

1257

R4190

NOMESCO Finland

Nutritional therapy

2.5

18.3

117

482

JAH01

NOMESCO Finland

Laparoscopy

2.2

18.3

155

724

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.4

18.3

103

ZYY01, ,

SPAT

7.5

18.2

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

18.2

333

2023

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.5

18.2

119

496

J01DA09

ATC

[U] cefadroxil

1.5

18.0

623

4443

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

18.0

137

612

EB1VA, ,

NOMESCO Finland

1.6

17.9

475

3182

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

17.9

854

6515

A03

ICPC

Fever

1.6

17.8

545

3777

SFA20

NOMESCO Finland

Two-surface restoration

1.5

17.8

1496

12736

G72.9

ICD-10 Finland

Myopathy, unspecified

7.6

17.8

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.3

17.8

202

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.5

17.8

173

SAA04

NOMESCO Finland

Special examination of mouth

2.2

17.7

152

713

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

17.7

270

1554

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

17.7

145

668

M05BA07

ATC

risedronic acid; oral

4.3

17.6

106

IHZ04, ,

SPAT

3.0

17.6

266

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

17.6

135

605

M15.8

ICD-10 Finland

Other polyarthrosis

3.8

17.6

146

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.3

17.5

199

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

17.5

178

892

F60.5

ICD-10 Finland

Anankastic personality disorder

3.6

17.5

165

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

6.6

17.5

F93.89

ICD-10 Finland

Other childhood emotional disorders

3.9

17.4

133

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.1

17.4

171

846

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.6

17.4

106

427

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

17.4

251

1420

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

17.4

276

1609

RF120, ,

NOMESCO Finland

4.8

17.3

R01AD12

ATC

fluticasone furoate; nasal

1.5

17.3

924

7196

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.6

17.3

104

417

TQW40, ,

SPAT

1.9

17.2

232

1284

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

17.2

424

2788

M25.9

ICD-10 Finland

Joint disorder, unspecified

4.3

17.2

104

J35.0

ICD-10 Finland

Chronic tonsillitis

1.9

17.1

224

1227

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

17.1

146

684

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

17.0

332

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.9

17.0

293

Z01.7

ICD-10 Finland

Laboratory examination

1.6

17.0

415

2721

R21

ICPC

Throat symptom/complaint

1.5

17.0

748

5599

XG405

NOMESCO Finland

Education on PEF monitoring

4.2

17.0

109

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

17.0

330

2038

F48.0

ICD-10 Finland

Neurasthenia

19.4

16.9

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

3.3

16.9

194

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.0

16.8

195

1026

U07

ICPC

Urine symptom/complaint other

2.0

16.8

187

970

SPAT1106

SPAT

Acupuncture

5.2

16.7

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

16.7

154

743

R06AE09

ATC

levocetirizine; oral

1.6

16.7

414

2723

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

12.8

16.6

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

16.6

246

1402

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

16.6

134

613

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

16.6

127

568

Z00.8

ICD-10 Finland

Other general examinations

1.9

16.6

211

1145

J01

ICD-10 Finland

Acute sinusitis

1.9

16.6

205

1102

1220

FHL

Arthroscopy

2.9

16.5

287

SPAT1211

SPAT

Application of soft bandage

2.0

16.5

197

1047

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

6.1

16.4

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

5.4

16.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

16.4

283

1690

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.7

16.4

322

K07.68

ICD-10 Finland

Other disorders of the jaw joint

4.1

16.3

108

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

16.3

131

598

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

16.3

140

657

L19

ICPC

Muscle symptom/complaint NOS

2.6

16.2

364

SPAT1283

SPAT

Restricted health certificate

1.5

16.2

651

4774

SPAT1059

SPAT

Spirometry at the office

2.5

16.2

105

436

M25.4

ICD-10 Finland

Effusion of joint

3.9

16.2

122

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

16.2

519

3626

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.5

16.2

400

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

16.2

215

1184

SPAT1260

SPAT

Consultation of another employee

1.7

16.1

373

2410

R12

ICD-10 Finland

Heartburn

1.9

16.1

224

1251

R13

ICD-10 Finland

Dysphagia

2.2

16.1

144

687

9245

FHL

Reconstruction or plastic surgery of ankle ligaments

7.1

16.1

N06AX05

ATC

trazodone; oral

2.8

16.1

302

N06AX17

ATC

milnacipran; oral

4.2

16.1

105

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.3

16.1

J20

ICD-10 Finland

Acute bronchitis

1.8

16.1

268

1583

U02

ICPC

Urinary frequency/urgency

1.6

16.0

377

2447

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.2

16.0

137

643

ZXA10

NOMESCO Finland

Bilateral

1.7

15.9

332

2088

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.6

15.9

142

N28

ICPC

Limited function/disability (N)

4.4

15.9

M43.0

ICD-10 Finland

Spondylolysis

3.5

15.8

152

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

15.8

182

954

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

15.8

122

548

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.8

15.8

277

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

15.8

1796

16022

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.8

15.8

294

H01

ICPC

Ear pain/earache

1.6

15.7

371

2408

R29

ICPC

Respiratory symptom/complaint other

2.0

15.7

180

943

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.4

15.6

168

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

15.6

173

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.6

15.6

371

WX290

NOMESCO Finland

Other blockage of nerve

1.4

15.6

1341

11326

ZX114

NOMESCO Finland

Intramuscular

3.9

15.6

121

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

15.5

378

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.5

15.5

396

N07CA01

ATC

betahistine; oral

2.3

15.5

119

533

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.4

15.5

112

489

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

15.5

350

2247

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.7

15.4

332

RS222, ,

NOMESCO Finland

4.7

15.4

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

5.8

15.4

D11

ICPC

Diarrhoea

1.6

15.4

375

2454

R03BB01

ATC

ipratropium bromide; inhalant

3.4

15.4

165

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

5.2

15.3

E66.8

ICD-10 Finland

Other obesity

1.9

15.3

191

1030

SPAT1312

SPAT

General health counselling

1.5

15.3

779

5976

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.5

15.2

406

NGE60

NOMESCO Finland

Plastic repair of patellar ligaments, open

4.7

15.2

R55

ICD-10 Finland

Syncope and collapse

2.0

15.2

182

968

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.4

15.2

106

456

A99

ICPC

Disease/condition unspecnature/site

1.8

15.1

237

1375

EMB10

NOMESCO Finland

Tonsillectomy

1.8

15.1

221

1255

S21

ICPC

Skin texture symptom/complaint

1.7

15.0

338

2167

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

4.1

15.0

102

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.2

15.0

134

640

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

15.0

379

TAB20

NOMESCO Finland

Epidural puncture

5.4

15.0

J01FA01

ATC

erythromycin; systemic

1.6

14.9

400

2677

K07.61

ICD-10 Finland

Cracking jaw joint

2.5

14.9

386

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.0

14.9

107

N05CD07

ATC

temazepam; oral

2.1

14.8

150

751

R07.0

ICD-10 Finland

Pain in throat

1.8

14.8

246

1451

R06AX26

ATC

fexofenadine; oral

1.8

14.8

215

1218

C08CA05

ATC

nifedipine; systemic

2.4

14.7

406

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

2.2

14.7

123

572

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.6

14.7

323

N03AF02

ATC

oxcarbazepine; oral

2.6

14.7

329

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

14.7

189

1030

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.6

14.6

136

M70.7

ICD-10 Finland

Other bursitis of hip

2.9

14.5

234

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.4

14.5

156

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.3

14.5

161

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

14.5

509

3616

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

14.5

122

568

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.1

14.5

197

S80.0

ICD-10 Finland

Contusion of knee

1.8

14.5

224

1293

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.7

14.5

302

J01DA06

ATC

[U] cefuroxime

1.7

14.4

322

2058

M03AX01

ATC

botulinum toxin; parenteral

2.9

14.4

246

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.7

14.4

297

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

15.5

14.4

SXC05

NOMESCO Finland

Other oral or dental procedure

1.8

14.3

205

1155

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.5

14.3

393

R03AC12

ATC

salmeterol; inhalant

2.6

14.3

327

A02BA04

ATC

nizatidine; systemic

2.2

14.3

116

532

B02AA02

ATC

tranexamic acid; systemic

1.5

14.3

455

3164

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.7

14.2

276

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.1

14.2

140

694

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

14.2

184

SFA30

NOMESCO Finland

Three-surface restoration

1.4

14.2

924

7387

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

14.1

131

634

NG1DA

NOMESCO Finland

X-ray of knees

3.8

14.1

111

D07AC01

ATC

betamethasone; topical

1.4

14.1

759

5859

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.5

14.1

144

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

14.1

116

535

ZXE00

NOMESCO Finland

One hour or less

1.4

14.1

861

6802

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.5

14.1

378

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

14.0

135

663

R4180

NOMESCO Finland

Podiatric therapy

4.6

14.0

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.3

14.0

160

M02AA15

ATC

diclofenac; topical

2.1

14.0

129

624

R03AK11

ATC

formoterol and fluticasone; inhalant

2.9

13.9

234

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.4

13.9

423

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

13.9

738

5681

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.7

13.9

117

A06AC51

ATC

ispaghula, combinations; oral

2.3

13.9

106

474

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

3.2

13.9

176

SPAT1263

SPAT

Sampling

1.4

13.9

947

7623

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

13.9

102

449

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

13.9

273

1688

F32

ICD-10 Finland

Depressive episode

1.9

13.9

189

1049

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.7

13.8

286

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.1

13.8

131

640

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

13.8

339

F32.8

ICD-10 Finland

Other depressive episodes

2.8

13.8

252

M76.0

ICD-10 Finland

Gluteal tendinitis

2.7

13.7

281

R09

ICPC

Sinus symptom/complaint

1.7

13.7

282

1763

A92

ICPC

Allergy/allergic reaction NOS

2.1

13.7

125

601

XQ820

NOMESCO Finland

Exposure to medicinal substance

5.3

13.7

S33.6

ICD-10 Finland

Sprain and strain of sacroiliac joint

13.7

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

13.7

694

5294

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

13.7

260

1592

RF220, ,

NOMESCO Finland

4.2

13.7

R83

ICPC

Respiratory infection other

1.4

13.7

816

6413

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.5

13.6

347

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

5.1

13.6

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

13.6

396

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.7

13.6

271

L04

ICPC

Chest symptom/complaint

1.9

13.5

161

855

A97

ICPC

No disease

1.5

13.5

467

3304

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

13.5

132

653

XX9XE

NOMESCO Finland

Other ultrasound examination

5.2

13.4

WVA30, ,

SPAT

2.1

13.4

126

613

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

13.4

245

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

5.6

13.4

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.6

13.4

291

ZX100

NOMESCO Finland

Oral

4.4

13.3

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.0

13.3

157

830

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

13.3

183

1018

SBA10

NOMESCO Finland

Measurement of salivary flow rate

4.5

13.3

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.3

13.3

106

483

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

6.3

13.3

SPAT1395

SPAT

Health check-up of persons outside student and working life

2.8

13.3

246

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.1

13.3

126

616

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

13.2

232

1389

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

3.8

13.2

103

OAB44, ,

SPAT

1.6

13.2

317

2064

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

4.3

13.1

OAB25, ,

SPAT

4.3

13.1

J01FA15

ATC

telithromycin; oral

1.7

13.1

227

1354

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

13.1

105

480

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

13.1

934

7554

P80

ICPC

Personality disorder

4.8

13.1

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

4.5

13.1

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.0

13.0

137

696

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

2.4

13.0

355

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

12.9

256

1584

SPAT1360

SPAT

Extensive global examination

2.1

12.9

132

663

RF210, ,

NOMESCO Finland

2.6

12.9

290

M05BX04

ATC

denosumab; parenteral

2.5

12.9

350

M07.3

ICD-10 Finland

Other psoriatic arthropathies

4.3

12.9

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.7

12.9

250

T82

ICPC

Obesity

2.0

12.9

141

727

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.4

12.8

351

EBA00

NOMESCO Finland

Extraction of tooth

1.4

12.8

855

6829

B01AA03

ATC

warfarin; systemic

2.0

12.8

145

756

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.5

12.8

346

H02

ICPC

Hearing complaint

1.8

12.8

206

1204

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.3

12.7

149

H02AA02

ATC

fludrocortisone; oral

5.8

12.7

M06

ICD-10 Finland

Other rheumatoid arthritis

5.8

12.7

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.0

12.7

132

667

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

12.7

299

1934

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.0

12.7

M19.2

ICD-10 Finland

Other secondary arthrosis

4.2

12.7

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.9

12.7

213

K59.01

ICD-10 Finland

Constipation outlet obstruction type

3.5

12.7

120

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.8

12.6

188

1072

R35

ICD-10 Finland

Polyuria

2.2

12.6

105

487

N17

ICPC

Vertigo/dizziness

1.7

12.6

262

1642

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

12.6

197

1140

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

4.6

12.6

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

12.5

202

1180

N05AX12

ATC

aripiprazole; systemic

2.0

12.5

141

734

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.9

12.5

209

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

+∞

12.5

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.9

12.5

160

870

K11.2

ICD-10 Finland

Sialoadenitis

2.4

12.5

368

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

6.2

12.5

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

12.5

356

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

12.4

1003

8254

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

130.7

12.4

H93.1

ICD-10 Finland

Tinnitus

2.0

12.4

144

757

G04CA02

ATC

tamsulosin; oral

2.3

12.4

413

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.3

12.4

ACC51

NOMESCO Finland

Release of median nerve

1.9

12.4

173

967

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

12.4

236

1445

U29

ICPC

Urinary symptom/complaint other

2.7

12.4

261

K04.0

ICD-10 Finland

Pulpitis

1.7

12.4

270

1713

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

12.4

117

571

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.3

12.4

420

F29

ICPC

Eye symptom/complaint other

1.7

12.3

264

1667

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.1

12.3

121

599

XQ802

NOMESCO Finland

Epicutan test

2.0

12.3

128

647

M01AB01

ATC

indometacin; systemic, rectal

2.5

12.3

297

S22.3

ICD-10 Finland

Fracture of rib

2.1

12.3

119

586

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

12.3

106

499

M19.8

ICD-10 Finland

Other specified arthrosis

2.4

12.3

371

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.5

12.2

298

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.5

12.2

118

R52.0

ICD-10 Finland

Acute pain

2.2

12.2

100

461

D02

ICPC

Abdominal pain epigastric

1.8

12.2

176

994

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.0

12.2

126

636

R03AC13

ATC

formoterol; inhalant

2.2

12.2

106

501

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.0

12.2

185

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.4

12.1

373

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.0

12.1

131

672

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.7

12.1

239

1477

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

4.1

12.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

12.1

183

1049

M01AE01

ATC

ibuprofen; systemic, rectal

1.8

12.1

2178

20617

N06AA12

ATC

doxepin; systemic

2.3

12.1

393

WW200, ,

SPAT

1.4

12.0

582

4384

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.3

12.0

387

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

12.0

109

524

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

12.0

368

2531

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

12.0

139

731

D07AC13

ATC

mometasone; topical

1.4

12.0

607

4611

G44.8

ICD-10 Finland

Other specified headache syndromes

2.7

12.0

231

H02BX01

ATC

methylprednisolone, combinations; systemic

2.6

12.0

254

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.1

12.0

111

538

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

12.0

121

606

M77.0

ICD-10 Finland

Medial epicondylitis

2.4

12.0

332

I49.1

ICD-10 Finland

Atrial premature depolarization

2.5

11.9

320

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

11.9

121

608

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

11.8

248

1557

K07.6

ICD-10 Finland

Temporomandibular joint disorders

3.8

11.8

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.8

11.8

210

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.9

11.8

199

K59.0

ICD-10 Finland

Constipation

2.1

11.8

116

575

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

11.8

105

501

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

14.7

11.8

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.0

11.8

167

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

11.8

103

488

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

11.8

590

4471

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.6

11.8

285

1856

N05BA12

ATC

alprazolam; oral

1.7

11.8

211

1271

R03BC03

ATC

nedocromil; inhalant

1.9

11.8

145

779

E87.6

ICD-10 Finland

Hypokalaemia

2.7

11.7

245

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.7

11.7

228

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

30.2

11.6

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

11.6

282

SPAT1235

SPAT

Mental health, emotional support

3.8

11.6

SPAT1254

SPAT

Administration of medicine

1.6

11.5

285

1864

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

5.3

11.5

D07AA02

ATC

hydrocortisone; topical

1.5

11.5

357

2459

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

11.5

195

1155

J30.3

ICD-10 Finland

Other allergic rhinitis

2.0

11.5

119

601

L84

ICPC

Back syndrome without radiat pain

2.0

11.5

122

622

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

5.0

11.5

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

11.5

181

1051

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.1

11.4

154

U71

ICPC

Cystitis/urinary infection other

1.8

11.4

187

1097

SGA01

NOMESCO Finland

Emergency treatment

1.5

11.4

442

3188

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

11.4

130

680

NXL00

NOMESCO Finland

Biopsy of muscle

11.9

11.3

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.3

11.3

404

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.1

11.3

101

483

M01CB01

ATC

sodium aurothiomalate; parenteral

3.9

11.3

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

11.3

304

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

2.7

11.3

227

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

11.3

100

477

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.8

11.3

199

C05AA08

ATC

fluocortolone; rectal, topical

1.7

11.2

239

1506

R31

ICD-10 Finland

Unspecified haematuria

2.1

11.2

105

511

M25.8

ICD-10 Finland

Other specified joint disorders

4.9

11.2

WX199

NOMESCO Finland

Other local analgesia

2.7

11.2

211

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.8

11.1

189

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.4

11.1

312

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.2

11.1

141

Y96.9

ICD-10 Finland

Unspecified type of accident

3.0

11.1

162

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

11.1

116

588

Z2221

NOMESCO Finland

Medical doctor

1.4

11.1

612

4710

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

11.1

236

1488

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

11.0

215

1324

K04.08

ICD-10 Finland

Other specified pulpit

1.6

11.0

244

1553

R5599, ,

SPAT

8.6

11.0

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

5.8

11.0

A27

ICPC

Fear of other disease NOS

2.1

11.0

110

549

GX2D5

NOMESCO Finland

Sleep oximetry

5.0

11.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

11.0

756

6035

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

3.7

11.0

Z30.2

ICD-10 Finland

Sterilization

1.6

10.9

295

1969

N06AB05

ATC

paroxetine; oral

1.9

10.9

149

827

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

10.9

153

J01CA08

ATC

pivmecillinam; oral

1.3

10.9

1166

9954

ZYC02

NOMESCO Finland

Remote contact by video link

5.4

10.9

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

2.6

10.9

249

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

10.9

124

649

OAB72, ,

SPAT

2.6

10.9

255

R01AD11

ATC

triamcinolone; nasal

1.7

10.9

201

1221

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

10.8

213

1315

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.7

10.8

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

10.8

348

OAA46, ,

SPAT

5.2

10.8

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.6

10.8

250

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.7

10.8

204

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.2

10.7

413

K11.7

ICD-10 Finland

Disturbances of salivary secretion

28.1

10.7

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

17.9

10.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.9

10.7

171

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

4.7

10.7

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.9

10.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

10.6

288

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

10.6

113

577

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

10.6

217

1354

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

10.6

645

5040

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

10.6

341

2366

M01CB03

ATC

auranofin; oral

8.0

10.6

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

10.6

161

925

LCA16

NOMESCO Finland

Destruction of endometrium

2.7

10.6

206

L29.9

ICD-10 Finland

Pruritus, unspecified

2.3

10.5

358

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

10.5

117

607

ZXD20

NOMESCO Finland

Day surgery

1.6

10.5

267

1757

K11.9

ICD-10 Finland

Disease of salivary gland, unspecified

5.0

10.5

T93.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of lower limb

4.0

10.5

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

10.5

201

1233

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

10.4

K08.3

ICD-10 Finland

Retained dental root

1.9

10.4

123

652

NHF25

NOMESCO Finland

Operation for debridement of ankle joint, arthroscopic

3.9

10.4

P74

ICPC

Anxiety disorder/anxiety state

1.7

10.4

179

1066

A01AB09

ATC

miconazole; local oral

1.8

10.4

159

915

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.3

10.4

354

R5140, ,

SPAT

3.6

10.4

N06AG02

ATC

moclobemide; oral

2.2

10.4

380

K92.1

ICD-10 Finland

Melaena

2.4

10.4

304

WX402

NOMESCO Finland

General anaesthesia

1.4

10.4

501

3762

TEG00

NOMESCO Finland

Punction of mandibular joint

12.1

10.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

10.3

539

4102

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

10.3

193

1176

N06AA04

ATC

clomipramine; systemic

3.1

10.3

132

TKC22

NOMESCO Finland

Catheterisation instruction

4.3

10.3

SFA00

NOMESCO Finland

Small restoration

1.5

10.3

325

2246

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.0

10.3

148

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.3

10.3

117

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.8

10.2

181

WX204

NOMESCO Finland

Axillary plexus blockaced

2.3

10.2

318

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

10.2

131

713

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

10.2

324

2240

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.2

10.2

415

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.0

10.2

154

U05

ICPC

Urination problems other

2.3

10.2

344

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

10.2

363

2571

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

10.2

133

K29.7

ICD-10 Finland

Gastritis, unspecified

2.3

10.2

319

AXX01, ,

SPAT

3.2

10.2

128

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

13.2

10.2

M12.3

ICD-10 Finland

Palindromic rheumatism

13.2

10.2

OAB42, ,

SPAT

1.5

10.1

324

2245

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

10.1

532

4053

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

10.1

774

6265

J34.2

ICD-10 Finland

Deviated nasal septum

2.1

10.1

478

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

3.1

10.1

134

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.1

10.1

431

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.3

10.1

327

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

11.3

10.0

L50.3

ICD-10 Finland

Dermatographic urticaria

2.5

10.0

247

J01MA14

ATC

moxifloxacin; systemic

1.8

10.0

156

902

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

3.0

10.0

145

EGA00

NOMESCO Finland

Arthroscopy of mandibular joint

9.2

10.0

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.6

10.0

249

1631

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

10.0

136

755

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

10.0

328

GX1E5, ,

SPAT

3.6

9.9

E000006, ,

ATC

1.8

9.9

143

808

1410

FHL

Laparoscopy

2.4

9.9

285

W19

ICD-10 Finland

Unspecified fall

1.7

9.9

178

1073

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

2.2

9.9

368

K58

ICD-10 Finland

Irritable bowel syndrome

2.1

9.9

414

N02CD06

ATC

rimegepant; oral

3.2

9.9

120

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

16.8

9.9

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.0

9.9

103

523

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

9.9

371

2656

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

12.2

9.8

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.0

9.8

108

558

B81

ICPC

Anaemia vit B12/folate deficiency

2.6

9.8

208

R01AD01

ATC

beclometasone; nasal

1.5

9.8

340

2393

M01AB16

ATC

aceclofenac; oral

2.7

9.8

191

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

26.1

9.8

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

4.4

9.8

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.9

9.8

126

687

P25

ICPC

Phase of life problem adult

1.8

9.8

152

879

N04BC09

ATC

rotigotine; transdermal

10.7

9.8

NGH20

NOMESCO Finland

Reduction of dislocation of knee joint, open

4.7

9.8

M01AG01

ATC

mefenamic acid; oral

2.3

9.8

306

A07EA06

ATC

budesonide; oral, local oral

2.1

9.8

443

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.0

9.7

109

567

NHE15

NOMESCO Finland

Suture or reinsertion of ligament of ankle

3.5

9.7

D19

ICPC

Teeth/gum symptom/complaint

1.3

9.7

804

6572

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.2

9.7

364

R07.2

ICD-10 Finland

Precordial pain

3.2

9.7

116

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.5

9.7

227

N81.1

ICD-10 Finland

Cystocele

1.9

9.7

125

682

XKC03

NOMESCO Finland

Water cystometry

2.7

9.7

198

A07EC02

ATC

mesalazine; oral, rectal

1.9

9.7

117

625

E66

ICD-10 Finland

Obesity

1.7

9.7

172

1034

Z11

ICPC

Compliance/being ill problem

4.2

9.6

K04

ICPC

Palpitations/awareness of heart

1.9

9.6

129

713

L14

ICPC

Leg/thigh symptom/complaint

1.7

9.6

168

1005

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.4

9.6

271

L04AB05

ATC

certolizumab pegol; parenteral

3.9

9.6

SPAT1311

SPAT

Counselling and guidance related to occupational health

2.0

9.6

501

L04AD01

ATC

ciclosporin; systemic

2.9

9.6

149

QDH05

NOMESCO Finland

Correction of deformity of toe nail

11.4

9.6

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

3.6

9.5

ZXD05

NOMESCO Finland

Urgent procedure

1.4

9.5

651

5167

EC1VA, ,

NOMESCO Finland

1.9

9.5

114

607

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

9.5

208

1320

WX723

NOMESCO Finland

CPAP therapy

2.1

9.5

435

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.9

9.4

150

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

933

3371

3.94

216.31

1.7

1.3

387.55

393.14

titre

0.05

196

601

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1075

4319

3.75

211.84

1.6

1.3

14.35

8.82

u/ml

0.81

518

1835

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1092

4716

3.47

187.05

1.6

1.3

25.41

23.03

iu/ml

0.24

308

1340

(3015171) Extractable nuclear Ab [Units/volume] in Serum

410

899

5.32

180.02

1.4

1.2

0.27

0.43

u/ml

0.65

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1006

4744

2.96

138.62

2.2

1.9

104.54

149.95

u/l

2.46

966

4527

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2094

15180

4.60

127.93

7.1

3.7

9.15

9.54

mm/h

1.11

2036

14402

(3006315) Basophils [#/volume] in Blood

1667

10641

2.97

124.10

8.2

6.0

0.04

e9/l

0.35

1522

9326

(3019198) Lymphocytes [#/volume] in Blood

1696

10938

3.00

123.61

8.2

6.0

2.05

1.98

e9/l

2.63

1581

9863

(3001604) Monocytes [#/volume] in Blood

1659

10627

2.93

121.44

8.1

6.0

0.53

e9/l

0.84

1522

9323

(3013115) Eosinophils [#/volume] in Blood

1692

11019

2.93

118.72

8.4

6.2

0.18

e9/l

0.06

1584

9832

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2023

14610

3.83

117.69

9.2

7.0

71.51

73.80

u/l

2.93

1972

13921

(3013650) Neutrophils [#/volume] in Blood by Automated count

1766

11823

3.01

116.52

10.3

8.8

3.96

3.94

e9/l

0.23

1620

10366

(3023420) DNA double strand Ab [Units/volume] in Serum

332

889

4.19

111.29

2.0

1.4

4.85

4.45

iu/ml

0.11

181

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1382

8380

2.58

107.25

5.5

6.0

1.22

mmol/l

1.77

1250

7283

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1494

9737

2.48

94.04

3.2

2.4

75.49

74.38

nmol/l

0.82

1426

9180

(3022096) Basophils/Leukocytes in Blood

1485

9698

2.45

92.32

8.2

6.0

0.68

0.69

0.36

1429

9099

(3019069) Monocytes/Leukocytes in Blood

1486

9719

2.45

91.89

8.3

6.0

8.18

8.20

0.08

1432

9163

(3002030) Lymphocytes/Leukocytes in Blood

1526

10112

2.46

91.44

8.1

5.9

30.70

29.86

2.89

1478

9635

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1221

7342

2.39

91.24

5.2

5.5

1.22

mmol/l

0.62

1157

6844

(3006504) Eosinophils/Leukocytes in Blood

1482

9700

2.44

91.19

8.2

5.9

2.65

2.75

1.33

1431

9123

(3018010) Neutrophils/Leukocytes in Blood

1503

9943

2.43

89.59

7.9

5.8

55.45

56.22

2.10

1469

9539

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

237

592

4.34

86.43

1.9

1.3

0.22

0.24

g/l

1.77

225

556

(3008898) HLA-B27 [Presence]

362

1213

3.35

86.09

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

247

649

4.14

84.15

1.4

1.1

7.21

2.62

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

231

580

4.31

83.60

1.4

1.1

2.09

2.16

u/ml

0.04

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

238

618

4.17

82.34

1.9

1.3

1.21

1.22

g/l

0.31

227

582

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

229

583

4.25

81.32

1.4

1.2

14.15

2.72

u/ml

1.02

(3002582) Erythrocytes [#/volume] in Urine

1000

5741

2.30

80.33

3.9

2.8

43.87

73.67

e6/l

0.44

833

4233

(3036481) Cortisol [Moles/volume] in Serum or Plasma

505

2151

2.72

77.69

2.4

2.1

357.77

385.33

nmol/l

2.41

477

2000

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1425

9569

2.25

76.71

5.6

8.84

9.76

umol/l

4.60

1368

9061

(3048689) Calprotectin [Mass/mass] in Stool

717

3677

2.37

73.83

2.7

2.5

97.26

99.82

ug/g

0.10

587

2918

(3005719) IgG [Mass/volume] in Serum or Plasma

397

1527

2.93

73.83

3.5

2.6

9.74

10.35

g/l

3.62

373

1428

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1009

5977

2.21

73.33

3.1

2.5

55.35

56.38

u/l

0.15

962

5565

(3024561) Albumin [Mass/volume] in Serum or Plasma

1195

7582

2.18

72.79

4.6

4.4

37.28

37.15

g/l

0.43

1139

7166

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

204

527

4.15

70.83

1.3

1.1

14.90

22.11

u/ml

0.29

(3018418) pH of Serum or Plasma

878

4982

2.22

70.35

3.4

3.6

7.39

7.40

3.37

605

3456

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

183

441

4.42

69.61

1.3

1.1

1.33

5.71

u/ml

0.47

(3018095) Leukocytes [#/volume] in Urine

1139

7213

2.13

68.30

4.9

3.4

37.41

74.85

e6/l

3.27

885

4662

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1184

7613

2.12

68.16

2.2

1.9

99.17

98.25

pmol/l

0.31

670

4107

(3032080) INR in Blood by Coagulation assay

1075

6700

2.12

66.79

8.9

7.3

1.08

inr

0.06

921

5484

(3035350) Ketones [Presence] in Urine by Test strip

1580

11392

2.19

66.72

4.9

3.4

6.73

2.55

estimate

0.40

368

2409

(3021601) Nitrite [Presence] in Urine by Test strip

1566

11281

2.17

65.85

5.0

3.4

0.00

estimate

0.80

366

2384

(3021960) Folate [Moles/volume] in Serum or Plasma

821

4643

2.18

65.32

1.7

1.6

20.13

20.59

nmol/l

0.43

747

4142

(3013826) Glucose [Moles/volume] in Serum or Plasma

1515

10798

2.14

65.18

4.6

4.2

5.95

6.28

mmol/l

13.17

1448

9877

(3009261) Glucose [Presence] in Urine by Test strip

1581

11460

2.17

65.01

5.0

3.4

0.00

0.01

estimate

2.31

366

2335

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

396

1639

2.70

63.45

2.4

14.82

20.55

au/ml

1.31

234

(40758558) Short blood count panel - Blood

985

6042

2.09

62.77

6.4

5.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

915

5464

2.11

62.62

1.7

1.5

1.94

2.12

g/l

4.38

627

3594

(3015377) Calcium [Moles/volume] in Serum or Plasma

1014

6320

2.07

61.56

2.9

3.2

2.34

2.35

mmol/l

2.53

954

5899

(3030981) Hyaline casts [#/volume] in Urine by Automated count

328

1254

2.88

61.02

2.6

2.2

0.16

0.43

e6/l

1.94

298

1182

(3021589) Normoblasts [#/volume] in Blood

1360

9459

2.04

60.51

11.9

9.3

0.00

e9/l

0.68

1140

7734

(3000850) Epithelial cells [#/volume] in Urine

707

3870

2.18

60.20

3.0

2.4

7.66

8.85

e6/l

0.81

663

3498

(3037467) Urinalysis macro (dipstick) panel - Urine

1837

14325

2.31

60.19

5.8

4.0

3.80

3.39

—

(3030467) Casts [#/volume] in Urine by Automated count

842

4948

2.10

59.45

3.6

2.7

0.15

0.30

e6/l

5.00

674

3498

(3026782) Osmolality of Urine

628

3305

2.23

58.77

3.5

2.5

498.82

520.91

mosm/kgh2o

1.66

580

2898

(3026493) Urate [Moles/volume] in Serum or Plasma

775

4472

2.10

56.97

2.2

292.55

300.74

umol/l

1.99

709

4065

(40760892) CBC W Ordered Manual Differential panel - Blood

905

5559

2.02

55.79

5.7

4.1

—

(3021440) Promyelocytes/Leukocytes in Blood

377

1623

2.58

55.28

5.5

4.6

0.04

0.14

2.16

347

(3017181) Myelocytes/Leukocytes in Blood

387

1688

2.55

55.22

5.4

4.5

0.57

1.04

2.84

412

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

600

3172

2.20

55.03

2.4

2.6

485.28

585.55

ng/l

0.33

494

2563

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

865

5264

2.02

54.43

2.7

2.2

2.58

mg/l

0.00

778

4601

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

939

5885

1.99

54.31

3.3

2.6

14.52

41.22

ng/l

2.06

457

2707

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

357

1528

2.58

52.84

1.3

24.39

39.28

au/ml

0.90

(3025159) Blasts/Leukocytes in Blood

379

1670

2.51

52.77

5.7

4.8

0.01

0.57

0.94

333

(4034850) Laboratory test

193

593

3.46

51.80

9.7

7.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

524

2714

2.20

50.01

3.2

2.5

5.32

4.79

e6/l

0.29

319

1182

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

119

265

4.68

49.81

1.2

1.1

19.00

2.31

u/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1243

8765

1.89

48.80

4.7

3.2

1.71

0.09

estimate

0.47

297

1972

(3019550) Sodium [Moles/volume] in Serum or Plasma

2256

20004

4.52

48.08

16.6

11.4

139.72

139.64

mmol/l

1.28

2236

19578

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

587

3226

2.09

47.80

2.4

2.42

mmol/l

0.00

535

2888

(3028026) IgM [Mass/volume] in Serum or Plasma

294

1199

2.66

47.77

2.3

1.8

1.30

1.37

g/l

0.48

277

1128

(3002179) Metamyelocytes/Leukocytes in Blood

360

1621

2.44

47.51

4.7

4.4

0.35

0.77

3.11

394

(3019150) Specific gravity of Urine by Refractometry

808

4998

1.94

46.97

4.5

3.3

1.02

1.64

kg/l

0.80

530

3252

(3005322) IgE [Units/volume] in Serum or Plasma

396

1873

2.34

46.73

1.6

1.3

141.40

228.59

u/ml

1.00

372

1756

(3023103) Potassium [Moles/volume] in Serum or Plasma

2255

20054

4.39

46.43

16.7

11.5

3.89

3.90

mmol/l

2.36

2233

19571

(3012095) Magnesium [Moles/volume] in Serum or Plasma

500

2613

2.16

46.26

3.1

3.3

0.83

0.82

mmol/l

0.30

465

2492

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

985

6554

1.87

45.35

1.5

1.4

0.83

1.44

u/ml

1.13

307

1929

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2091

17913

2.57

44.78

6.0

4.8

14.43

14.32

pmol/l

1.49

2013

16945

(40768797) Stomach Pathology biopsy report

503

2671

2.12

44.47

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

918

6033

1.86

43.47

5.4

3.4

0.00

estimate

1.71

362

2303

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1052

7235

1.82

42.80

3.3

3.0

26.48

28.88

u/l

1.65

1013

6903

(3004616) Nuclear Ab [Presence] in Serum

102

229

4.61

42.24

1.4

1.2

—

(3015736) pH of Urine

1253

9106

1.81

42.22

4.1

3.0

6.24

0.05

699

5311

(3045414) Leukocytes [Presence] in Urine

380

1849

2.26

41.60

2.2

1.9

0.00

0.02

estimate

1.30

421

(3027135) IgG subclass 1 [Mass/volume] in Serum

217

4.67

41.28

1.7

1.4

6.53

6.20

g/l

0.35

164

(4062490) Immunoglobulin typing, IgG

213

4.71

41.27

1.8

1.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2188

19320

3.03

41.22

15.9

10.1

93.85

92.37

ml/min/173m2

3.40

2068

17463

(3028192) IgG subclass 2 [Mass/volume] in Serum

216

4.64

40.58

1.7

1.4

2.80

2.95

g/l

0.37

162

(3024139) IgG subclass 3 [Mass/volume] in Serum

216

4.64

40.58

1.7

1.4

0.32

0.38

g/l

1.03

163

(3011397) Hemoglobin [Presence] in Urine by Test strip

783

5010

1.85

39.54

4.7

3.3

0.20

0.24

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

101

241

4.33

38.73

1.3

1.1

23.61

53.02

u/ml

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

525

2964

1.99

38.66

3.1

2.4

1.11

1.26

e6/l

0.29

318

1436

(3004789) Transferrin [Mass/volume] in Serum or Plasma

486

2673

2.03

38.50

2.5

2.3

2.51

2.48

g/l

0.96

460

2474

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2279

20749

4.71

38.16

19.9

11.4

15.43

19.22

mg/l

10.34

2006

16614

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2224

20008

3.23

36.64

7.4

5.7

1.61

1.75

mu/l

10.19

2174

19185

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

599

3595

1.90

36.52

1.8

1.6

76820354.37

35529238.10

pmol/l

0.47

522

3158

(3023368) Bacteria identified in Blood by Culture

629

3840

1.87

36.34

4.0

3.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

427

2285

2.06

36.27

1.9

1.6

1082.88

1184.03

nmol/l

1.64

351

1773

(3022948) Iron [Moles/volume] in Serum or Plasma

515

2949

1.96

36.12

2.5

2.3

15.20

14.59

umol/l

1.15

493

2749

(3000330) Specific gravity of Urine by Test strip

213

848

2.66

35.98

3.4

2.6

1.02

ratio

0.51

192

739

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

160

546

3.07

35.97

1.4

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

198

4.52

35.42

1.2

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1606

12896

1.78

35.39

4.2

3.3

69.18

68.73

ug/l

0.05

1563

12331

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

437

2390

2.02

34.84

2.5

2.4

24.11

23.76

0.23

414

2217

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2142

19004

2.50

34.56

4.7

4.0

5.56

5.62

mmol/l

2.18

2059

17999

(3024980) IgG subclass 4 [Mass/volume] in Serum

121

358

3.51

34.29

1.6

1.5

0.45

0.56

g/l

1.32

287

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

257

1144

2.40

34.27

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

153

524

3.05

34.17

1.3

335.54

317.77

ug/g

0.37

257

(3031040) Bacteria [#/volume] in Urine by Automated count

1683

13794

1.78

33.48

5.8

4.0

452.93

1544.16

e6/l

1.05

146

(3019420) Tryptase [Mass/volume] in Serum or Plasma

167

4.73

33.26

1.4

1.5

4.90

7.01

ug/l

1.49

148

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

206

841

2.59

33.02

2.2

2.1

40.63

40.11

u/l

0.14

193

791

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

751

4977

1.75

32.33

1.9

1.8

0.70

0.83

mg/l

1.54

568

3726

(3022145) Colonoscopy Study observation

400

2185

2.00

31.75

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

106

5.49

29.34

1.9

2.1

1.92

1.85

umol/l

0.26

(3000475) Leukocytes [#/volume] in Synovial fluid

110

341

3.34

28.98

2.0

1.7

7297.01

10279.34

e6/l

0.51

238

(3038026) Centromere Ab [Units/volume] in Serum

111

5.33

28.94

1.3

1.1

24.76

23.44

u/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

5.67

28.84

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

847

5941

1.67

28.82

3.3

2.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

201

865

2.45

28.75

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

102

5.50

28.40

1.3

1.2

4.71

5.52

u/l

0.66

(3017732) Neutrophils [#/volume] in Blood

452

2668

1.86

28.15

2.8

4.25

4.50

e9/l

0.43

409

2418

(40759836) Histone Ab [Presence] in Serum by Immunoblot

178

4.26

28.10

1.2

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2307

21612

5.64

28.07

21.0

13.0

66.52

67.02

umol/l

0.73

2293

21379

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

183

4.20

27.95

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

423

2452

1.89

27.86

1.3

1.2

98.18

154.34

u/ml

2.26

167

967

(3044889) 12 lead EKG panel

1564

12862

1.65

27.45

3.5

3.0

—

0.33

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

332

1782

2.01

27.42

2.9

3.6

4.52

4.57

pmol/l

0.30

304

1618

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

393

2237

1.91

27.33

2.6

5.62

6.09

umol/l

0.22

331

1902

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

178

4.20

27.23

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

179

4.18

27.03

1.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

239

1154

2.19

26.08

3.3

3.6

4.36

4.74

kpa

2.88

231

1124

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

172

4.16

25.86

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

472

2890

1.79

25.86

3.0

153.80

318.12

ng/l

0.94

204

1566

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

170

4.15

25.40

1.2

1.1

—

(3002032) Base excess in Venous blood by calculation

262

1326

2.10

25.32

3.3

4.2

2.02

1.63

mmol/l

1.23

235

1148

(3012544) pH of Venous blood

267

1364

2.08

25.16

3.4

4.1

7.38

0.38

131

773

(3021447) Carbon dioxide [Partial pressure] in Venous blood

267

1369

2.07

24.91

3.4

4.1

5.86

5.78

kpa

0.74

258

1336

(3014051) Protein [Presence] in Urine by Test strip

898

6576

1.59

24.67

3.2

2.6

0.00

0.05

0.80

(3003458) Phosphate [Moles/volume] in Serum or Plasma

347

1957

1.91

24.64

4.1

5.7

1.05

1.06

mmol/l

0.13

324

1814

(3018333) Ribosomal P Ab [Presence] in Serum

164

4.11

24.03

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2298

21642

4.37

24.01

15.4

9.8

24.88

24.28

u/l

0.94

2278

21187

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

6.12

23.77

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

174

772

2.35

23.18

2.1

2.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

109

386

2.91

22.93

1.5

2.3

127.16

242.29

ug/l

1.81

356

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

400

2409

1.80

22.92

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

202

960

2.21

22.86

2.0

2.6

67.57

67.34

g/l

0.20

187

904

(3044640) Blood type and Crossmatch panel - Blood

902

6699

1.56

22.83

2.4

2.0

—

(3024263) Appearance of Synovial fluid

6.32

22.74

3.7

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

387

2324

1.80

22.34

2.1

2.2

29.47

29.04

0.49

372

2258

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

242

3.39

21.94

1.3

1.1

360.00

301.54

titre

—

(3023520) Reticulocytes [#/volume] in Blood

207

1013

2.14

21.75

1.8

2.8

71.37

73.22

e9/l

0.31

146

708

(3027945) Reticulocytes/Erythrocytes in Blood

270

1457

1.96

21.73

2.1

2.8

1.63

1.76

1.77

242

1313

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

166

746

2.32

21.46

1.5

1.6

0.03

0.15

iu/ml

0.68

111

(3033658) Prothrombin time (PT) actual/Normal

673

4727

1.59

21.39

4.0

3.5

98.22

97.50

0.37

650

4613

(3041096) Erythrocytes [Presence] in Urine by Automated

891

6675

1.54

21.29

4.0

2.7

0.17

0.20

estimate

0.05

295

1956

(3042936) Bacteria identified in Isolate by Culture

389

2377

1.76

21.07

2.1

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

290

1627

1.89

20.74

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2013

18139

1.78

20.62

5.5

4.7

36.35

37.22

mmol/mol

7.22

1947

17361

(3003327) Ova and parasites identified in Stool by Light microscopy

206

1029

2.10

20.50

1.9

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

109

413

2.72

20.22

1.8

1.2

18.26

5.76

iu/ml

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

136

4.12

20.19

1.1

0.13

8.03

nmol/l

0.86

(3025941) Bacteria identified in Stool by Culture

258

1405

1.94

20.17

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

271

1515

1.89

19.55

3.1

4.4

211.99

236.86

u/l

2.55

258

1452

(3045424) Erythrocytes [Presence] in Urine

186

913

2.13

19.36

2.2

1.9

0.00

0.02

estimate

1.71

338

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

257

1420

1.91

19.21

3.0

2.3

78.15

77.35

ml/min/173m2

0.13

124

573

(3022621) pH of Urine by Test strip

300

1743

1.83

19.15

2.6

2.2

6.11

6.18

0.70

217

1071

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

125

526

2.45

18.72

1.4

1.6

1494.36

8630.22

e6/l

0.47

406

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

252

3.13

18.62

1.2

1.3

0.52

0.54

nmol/l

0.25

246

(3004588) Protein electrophoresis panel - Serum or Plasma

154

713

2.24

18.55

2.2

2.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

368

2291

1.72

18.49

1.9

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

463

3076

1.63

18.11

1.7

1.45

1.35

3.25

411

2777

(3017315) Amylase [Enzymatic activity/volume] in Urine

4.54

18.00

1.4

1.2

178.65

321.20

u/l

0.66

(3044941) Cell count panel - Synovial fluid

268

3.02

17.97

1.8

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

124

530

2.41

17.96

1.2

1.4

3.44

3.66

mmol/l

2.05

118

505

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

679

4951

1.52

17.64

2.3

2.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

121

517

2.41

17.54

1.3

1.6

23.85

19.10

e6/l

0.12

375

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

115

4.15

17.52

2.9

388.15

814.27

u/ml

2.72

115

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

108

438

2.54

17.50

2.1

1.9

7.19

7.30

g/l

0.28

103

421

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

108

438

2.54

17.50

2.1

1.9

4.42

4.30

g/l

0.83

103

420

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

108

438

2.54

17.50

2.1

1.9

3.58

3.71

g/l

0.45

103

421

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

133

594

2.31

17.44

1.2

1.4

397.51

462.29

mg/l

1.45

127

571

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

240

1339

1.88

17.36

1.6

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

423

2.53

16.76

2.2

1.9

2.84

2.90

g/l

0.32

406

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

221

3.14

16.66

1.2

1.3

0.16

0.25

nmol/l

0.48

156

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

217

1192

1.90

16.45

3.0

3.6

63.73

74.11

ng/l

2.35

192

1075

(3009508) Creatinine [Moles/volume] in Urine

735

5541

1.48

15.90

2.8

3.3

7.48

7.72

mmol/l

0.64

652

4877

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

307

1892

1.72

15.86

2.4

2.3

30.96

37.08

u/l

1.79

244

1560

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

144

3.60

15.60

2.3

2.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

225

1272

1.85

15.58

2.6

2.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

226

1288

1.84

15.25

2.7

3.2

1.23

mmol/l

0.68

189

1098

(3052851) Hemolysis interference index of Serum or Plasma

103

440

2.40

14.97

2.7

0.75

2.08

index

2.78

231

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1204

10028

1.41

14.81

2.9

2.6

—

estimate

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

6.37

14.56

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

355

2.54

14.46

2.3

1.8

0.00

0.02

g/l

0.64

327

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

122

571

2.20

14.33

1.3

—

(3011412) CD3 cells [#/volume] in Blood

183

3.17

14.29

2.0

2.9

1578.12

1306.84

e6/l

0.99

159

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

389

2.45

14.16

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1737

15518

1.46

14.00

3.8

3.0

36.93

33.89

u/l

1.19

1688

14941

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

276

1714

1.69

13.79

1.7

1.6

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2333

22862

6.99

13.60

28.2

17.9

90.59

90.15

5.46

2323

22724

(3035941) MCH [Entitic mass]

2333

22862

6.99

13.60

28.2

17.8

30.16

30.03

3.50

2323

22724

(3007461) Platelets [#/volume] in Blood

2333

22859

7.03

13.58

28.4

17.9

274.83

267.99

e9/l

6.37

2316

22546

(3000060) B lymphocytes [#/volume] in Blood

4.45

13.56

1.7

2.7

0.20

0.15

e9/l

0.55

(3044290) Cell count panel - Cerebral spinal fluid

107

486

2.26

13.53

1.3

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

373

2.44

13.51

1.9

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

2333

22865

6.95

13.44

28.3

17.9

4.49

e12/l

0.01

2311

22515

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2333

22863

6.98

13.42

28.6

18.1

40.34

40.27

0.16

2323

22716

(3010813) Leukocytes [#/volume] in Blood

2333

22868

6.91

13.27

28.4

18.0

6.83

6.68

e9/l

2.51

2310

22507

(3000991) Gas panel - Venous blood

205

1184

1.80

13.22

5.8

8.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

396

2.38

13.17

2.4

2.1

0.25

0.56

g/l

0.85

358

(3000963) Hemoglobin [Mass/volume] in Blood

2333

22872

6.86

13.10

28.6

18.0

134.52

133.93

g/l

1.94

2325

22732

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

265

1662

1.67

12.73

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

196

1131

1.80

12.67

4.4

7.6

6.04

7.14

mmol/l

2.56

189

1103

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

172

3.07

12.44

1.0

1.1

1.05

1.06

u/l

0.05

(1001926) Buprenorphine [Presence] in Urine by Screen method

230

1398

1.72

12.41

2.0

1.9

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

227

2.78

12.38

1.1

196.29

207.65

mg/l

0.51

202

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

2.36

12.36

2.3

1.9

9.85

10.10

g/l

0.27

357

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

235

2.73

12.15

1.2

1.1

26.64

33.30

mg/l

1.92

196

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

105

3.66

12.05

1.9

2.4

9.11

9.97

mg/l

0.41

(44813793) Dust mix specific IgE antibody measurement

214

2.80

11.99

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

101

3.71

11.94

2.3

2.0

27.19

31.73

umol/l

1.55

(3000494) Fungus identified in Specimen by Culture

351

2398

1.55

11.78

1.6

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

310

2.47

11.76

4.9

3.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

120

605

2.04

11.66

1.3

1.1

—

(3023410) Appearance of Cerebral spinal fluid

258

2.60

11.62

1.6

1.9

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

118

3.43

11.52

2.4

1.8

46.41

40.54

0.29

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

119

604

2.02

11.36

1.3

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

188

2.86

11.24

1.2

0.54

0.63

ratio

1.00

107

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

216

2.73

11.24

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

171

985

1.79

11.12

1.6

13.48

9.80

u/ml

0.26

286

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

136

3.20

11.11

1.7

2.9

529.18

521.77

e6/l

0.04

107

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

163

927

1.82

11.06

1.5

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.75

11.01

1.3

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

155

870

1.84

10.98

2.1

2.0

4.44

5.47

ug/l

0.29

132

783

(42529406) Shigella sp [Presence] in Stool by Culture

119

612

2.00

10.96

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

420

2.19

10.71

1.1

6.43

3.11

0.71

(3004809) Band form neutrophils/Leukocytes in Blood

211

2.69

10.63

2.4

2.9

0.89

1.62

1.64

195

(3027008) Opiates [Presence] in Urine

267

1753

1.59

10.62

1.9

—

(3016879) Cocaine [Presence] in Urine

251

1625

1.61

10.59

1.9

2.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

3.58

10.48

3.1

2.9

126.80

107.33

au/ml

—

(3028300) Cannabinoids [Presence] in Urine

267

1760

1.58

10.44

2.0

1.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

106

3.43

10.42

1.2

0.31

0.29

g/l

1.21

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

105

528

2.04

10.31

2.1

1.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

164

2.90

10.29

1.7

1.5

15.95

21.89

umol/l

0.89

152

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

843

6903

1.35

10.20

2.0

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

264

1746

1.58

10.17

2.0

1.9

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

144

3.02

10.12

1.7

2.9

206.66

212.28

e6/l

0.09

120

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.47

10.04

1.2

1.79

1.70

iu/ml

0.07

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

392

2.19

10.02

1.3

4.70

4.04

u/ml

0.13

159

(40761511) CBC panel - Blood by Automated count

2258

21751

2.07

9.99

15.7

10.3

—

(3003396) Base excess in Arterial blood by calculation

221

1408

1.63

9.95

5.2

8.0

1.13

0.73

mmol/l

1.20

181

1131

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

343

2.26

9.84

2.5

1.8

0.00

g/l

-0.00

307

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

10.66

9.77

1.8

1.26

1.11

mg/l

0.10

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

403

2.15

9.75

1.3

1.2

3.00

2.84

u/ml

0.05

139

(21494755) Public health laboratory ask at order entry panel

200

3081

0.62

9.68

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

135

756

1.83

9.65

1.2

4.01

4.51

0.35

122

(3009343) pH of Capillary blood

149

860

1.78

9.65

2.7

3.3

7.42

0.11

125

731

(3016502) Oxygen saturation in Arterial blood

196

1222

1.66

9.61

5.7

8.7

95.54

96.36

0.81

189

1187

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

134

750

1.83

9.60

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

224

1446

1.61

9.55

1.1

—

108.53

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

152

888

1.76

9.45

2.8

3.3

5.08

5.14

kpa

0.56

146

863

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

178

2.73

9.43

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

259

1735

1.55

9.42

1.8

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

261

2.41

9.41

1.0

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

221

1428

1.60

9.39

5.3

7.9

12.95

13.71

kpa

1.11

214

1378

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

221

1428

1.60

9.39

5.3

7.9

5.03

5.06

kpa

0.19

216

1378

(3047007) Chlamydophila sp Ab [Presence] in Serum

443

2.07

9.38

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

112

596

1.92

9.38

2.1

1.9

—

(36660697) Celiac disease serology panel - Serum

313

2187

1.50

9.36

1.3

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

3.97

9.32

1.2

0.08

0.49

u/ml

0.69

(40768443) Skin Pathology biopsy report

141

812

1.78

9.21

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

231

1518

1.58

9.14

2.6

2.3

0.23

g/l

0.04

208

1444

(3019225) pH of Specimen

223

1455

1.59

9.09

2.9

3.2

7.38

7.34

2.24

177

1047

(3023323) Follitropin [Units/volume] in Serum or Plasma

357

2575

1.46

9.08

1.4

23.02

24.52

iu/l

0.39

307

2206

(1616796) Gas panel - Central venous blood

316

2.25

9.08

2.7

2.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.52

9.07

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

345

2475

1.46

9.02

2.3

5373.78

6361.12

u/l

0.23

105

995

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

9.06

9.02

1.2

0.54

0.29

iu/ml

—

(3011985) Renin [Units/volume] in Plasma

273

2.34

8.99

2.2

1.7

34.91

61.60

mu/l

0.79

254

(3016244) Insulin [Units/volume] in Serum or Plasma

218

2.51

8.98

2.9

3.5

31.11

27.02

mu/l

0.29

209

(3001186) Copper [Moles/volume] in Serum or Plasma

3.94

8.87

1.4

16.87

17.30

umol/l

0.13

(3007566) Smooth muscle Ab [Titer] in Serum

111

602

1.89

8.80

1.3

75.33

90.16

titre

0.53

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

174

2.68

8.72

1.3

2.23

1.89

mmol/l

0.41

161

(3023511) Choriogonadotropin [Units/volume] in Urine

194

1246

1.61

8.45

1.5

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

177

2.63

8.44

1.3

1.2

—

(3019977) pH of Arterial blood

217

1433

1.57

8.40

5.3

8.0

7.42

0.30

114

789

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

242

3470

0.66

8.33

1.7

1.8

3.48

3.30

ratio

1.64

174

2517

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

119

673

1.81

8.28

1.4

26.67

22.70

u/l

0.55

100

569

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

215

2.45

8.25

1.3

1.1

0.63

1.42

u/ml

1.12

103

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

292

2.23

8.13

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

292

2.23

8.13

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.25

8.07

1.3

—

(4198724) Urine methamphetamine measurement

148

2.73

7.94

1.9

2.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

154

2.69

7.91

2.2

1.8

42.57

54.53

0.87

(3048929) Epstein Barr virus Ab [Presence] in Serum

177

1132

1.61

7.86

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

265

2.26

7.79

3.5

3.0

30.67

32.71

umol/l

0.44

251

(44816559) Phosphatidylethanol [Mass/volume] in Blood

165

1040

1.63

7.77

1.6

0.21

0.27

mg/l

0.92

433

(3049717) Cytology report of Urine Cyto stain

298

2.18

7.75

2.0

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

460

3560

1.36

7.71

1.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

117

2.93

7.70

2.1

2.4

20.65

189.12

ug/l

0.51

109

(40768804) Tissue Pathology biopsy report

1013

8744

1.28

7.69

2.2

2.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

129

764

1.73

7.68

2.7

3.2

1.79

1.45

mmol/l

0.71

556

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

179

2680

0.64

7.54

1.6

3.58

3.42

mmol/l

1.10

119

1782

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.18

7.54

1.1

100.18

98.98

0.04

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.36

7.38

1.4

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1963

18502

1.38

7.36

21.5

14.0

13.36

13.32

0.83

1952

18268

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

421

1.96

7.34

2.0

0.83

1.86

ug/l

0.78

388

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

637

5216

1.30

7.18

2.2

2.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.08

7.16

1.1

102.64

95.44

0.71

(3020682) Albumin/Creatinine [Ratio] in Urine

558

4489

1.32

7.15

3.4

4.1

4.13

9.09

mg/mmol

3.89

329

2793

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

136

836

1.67

7.08

1.2

1.1

2.22

2.70

u/ml

0.19

428

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

251

2.22

7.03

1.6

1.4

347.90

378.63

pmol/l

0.24

224

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

688

5713

1.29

6.93

2.3

2.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

355

2.00

6.82

1.4

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.52

6.71

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

121

2.75

6.70

2.3

1.9

3.92

3.91

mmol/l

0.05

121

(3035285) Chloride [Moles/volume] in Venous blood

121

2.75

6.70

2.3

1.9

107.06

105.93

mmol/l

1.00

121

(3012516) Albumin [Mass/volume] in Urine

547

4437

1.30

6.53

2.8

3.4

25.19

48.51

mg/l

3.20

322

2773

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

128

792

1.65

6.52

1.6

2.2

69.12

3.95

iu/l

0.48

372

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

229

3174

0.69

6.50

1.5

1.6

1017.33

992.84

mu/l

0.18

197

2678

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

101

2.89

6.47

3.0

3.6

197.53

216.55

umol/l

0.12

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.66

6.47

1.2

1.4

111.53

78.16

nmol/l

0.76

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

485

1.82

6.41

1.6

1.8

—

(3036489) Thrombin time

130

815

1.63

6.30

1.8

2.3

19.68

20.58

2.10

108

692

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

18.06

6.26

2.7

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

504

1.80

6.24

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1628

0.59

6.20

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

231

1648

1.45

6.18

1.6

289.73

302.32

mu/l

0.35

214

1476

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

101

1650

0.59

6.17

1.5

1.16

ratio

0.00

984

(3008152) Bicarbonate [Moles/volume] in Arterial blood

120

743

1.65

6.12

4.9

7.6

24.19

24.31

mmol/l

0.13

115

710

(37208534) Antinuclear antibody arbitrary concentration in serum

3.10

6.04

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

102

1653

0.60

6.03

1.5

0.96

0.94

ratio

0.16

987

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

102

1653

0.60

6.03

1.5

1.03

1.20

ratio

1.95

994

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

124

777

1.63

6.03

2.4

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

288

2.04

6.03

2.6

2.3

17.34

16.86

0.75

282

(3033705) Calcium.ionized [Moles/volume] in Venous blood

117

2.67

5.99

2.4

1.9

1.21

1.20

mmol/l

0.52

117

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

217

1553

1.44

5.72

3.0

2.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2099

20159

1.40

5.69

5.0

4.5

2.89

2.85

mmol/l

0.93

2023

19303

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

211

2.15

5.45

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.87

5.42

1.4

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.87

5.42

1.4

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.87

5.42

1.4

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

4.87

5.42

1.4

1.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

234

1715

1.40

5.41

2.1

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

542

1.71

5.40

1.2

1.1

17.00

13.84

au/ml

0.18

154

(3010144) Erythrocytes [#/volume] in Synovial fluid

118

2.56

5.38

1.8

1.4

7277.45

92080.96

e6/l

0.82

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

136

2.45

5.38

1.5

1.7

1.55

5.71

nmol/l

1.24

(3002256) Pathology report gross observation

349

2729

1.33

5.35

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

117

1779

0.64

5.28

1.5

62.11

59.93

ug/l

0.24

101

1482

(3010838) Calcium [Moles/time] in 24 hour Urine

360

1.86

5.27

2.3

2.0

5.55

5.13

mmol/24h

0.52

331

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

230

1689

1.40

5.26

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

169

2.27

5.24

1.2

1.1

1.05

ratio

0.10

138

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

116

742

1.59

5.23

6.8

9.1

24.56

24.13

mmol/l

0.92

116

731

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

2.61

5.22

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.89

5.19

1.0

1.1

56.33

67.29

ng/l

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

106

669

1.61

5.06

2.4

2.7

143.37

162.96

2.58

101

642

(3002079) Sodium [Moles/time] in 24 hour Urine

104

2.61

5.06

1.5

143.23

146.54

mmol/24h

0.08

104

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

245

2.02

5.05

1.5

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

2.56

5.05

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

305

2359

1.34

5.04

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

149

1021

1.49

4.94

1.4

11.68

10.84

u/l

0.24

120

831

(3003888) Timothy IgE Ab [Units/volume] in Serum

115

745

1.57

4.93

1.1

5.31

5.47

u/ml

0.03

400

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1401

0.61

4.87

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

411

3331

1.28

4.82

2.2

2.0

—

(3042517) Benzodiazepines panel - Urine

4.23

4.82

2.3

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

487

4032

1.26

4.79

2.3

2.1

—

(3003181) Sodium [Moles/volume] in Urine

223

2.04

4.77

2.2

1.5

67.21

67.77

mmol/l

0.03

192

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.59

4.76

1.1

1.0

0.03

0.01

u/ml

—

(3012501) Base excess in Blood by calculation

293

1.90

4.75

2.6

2.5

1.76

2.47

mmol/l

1.90

173

(3010726) Horse dander IgE Ab [Units/volume] in Serum

110

713

1.57

4.72

1.2

1.1

1.23

1.82

u/ml

0.58

346

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

238

1.99

4.70

1.0

1.1

2.67

8.14

iu/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2080

20042

1.34

4.69

4.5

4.2

4.79

4.80

mmol/l

0.24

2011

19254

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2074

19980

1.33

4.65

4.4

4.1

1.50

1.53

mmol/l

3.60

1996

19127

(3038515) Glucose [Moles/volume] in Venous blood

241

1.97

4.55

3.3

2.4

6.33

6.97

mmol/l

1.70

234

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

562

1.63

4.52

1.2

1.3

251.94

246.54

u/ml

0.07

358

(3008757) Leukocyte morphology finding [Identifier] in Blood

123

2.37

4.49

1.6

3.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

108

708

1.55

4.43

1.1

0.23

0.99

u/ml

2.76

300

(4268621) Lupus anticoagulant assay

272

1.89

4.42

2.5

2.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

637

1.58

4.40

1.2

1.1

1.41

4.11

u/ml

3.33

303

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

196

1447

1.39

4.37

1.7

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

474

1.67

4.36

1.1

1.4

141.92

151.08

au/ml

0.23

127

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.11

4.36

1.1

—

62.67

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

190

2.07

4.35

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

157

2.18

4.34

1.4

2.0

33.50

31.91

1.75

157

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

115

769

1.52

4.32

2.1

2.5

107.76

98.67

ng/l

0.07

678

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

118

794

1.51

4.30

1.5

0.36

0.47

nmol/l

1.14

643

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1199

0.61

4.25

1.1

0.58

0.60

ratio

—

128

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.05

4.24

1.1

—

81.33

—

(3028433) Virus identified in Specimen by Culture

3.05

4.24

1.1

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1366

0.64

4.23

1.5

—

(3005033) Fetal Nuchal fold Thickness US

1342

0.63

4.23

1.5

1.20

1.25

0.69

963

(3022313) Gas panel - Capillary blood

588

1.59

4.22

2.8

3.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

588

1.59

4.22

1.1

4.18

5.53

u/ml

0.32

250

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

248

1.91

4.22

3.9

3.7

1.25

1.99

ratio

1.11

129

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

193

2.04

4.19

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

153

2.17

4.18

1.4

1.2

242.86

197.78

titre

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

292

1.83

4.17

3.7

26.58

48.77

mg/l

0.94

256

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

292

1.83

4.17

3.7

22.54

47.17

mg/l

1.34

255

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

543

1.61

4.16

1.1

1.0

0.07

0.25

u/ml

1.49

155

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.54

4.13

1.7

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.72

4.08

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

104

2.42

4.06

1.3

1.6

126.48

128.11

nmol/l

0.08

104

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1245

0.63

4.05

1.1

1.61

1.58

g/l

0.34

1245

(3000093) Morphology [Interpretation] in Blood Narrative

123

2.29

4.04

1.1

1.2

—

(4024509) Urine culture

127

880

1.47

4.03

2.0

1.8

—

(3016031) Almond IgE Ab [Units/volume] in Serum

4.21

4.01

1.0

0.10

0.63

u/ml

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

5.57

3.97

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

151

2067

0.71

3.97

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

233

1.91

3.93

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

233

1.91

3.93

1.5

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1269

0.64

3.89

1.1

0.87

g/l

0.12

1269

(3017446) Testosterone [Moles/volume] in Serum or Plasma

109

739

1.50

3.87

2.5

2.0

8.09

8.23

nmol/l

0.06

677

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

101

2.39

3.81

3.7

3.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

236

1.88

3.79

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

229

1.89

3.78

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

519

1.58

3.72

1.5

1.6

301.08

368.96

mu/l

2.06

415

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.84

3.69

1.0

1.1

0.06

0.02

u/ml

0.78

(3020874) Milk IgE Ab [Units/volume] in Serum

240

1.85

3.62

1.1

0.42

2.58

u/ml

0.84

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1955

18809

1.24

3.61

3.9

3.6

1.27

1.20

mmol/l

4.28

1881

17925

(3037121) Protein [Mass/volume] in Urine

571

1.54

3.61

3.1

3.2

202.63

318.64

mg/l

1.19

249

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

205

1.92

3.58

1.2

1.1

118.92

117.71

pmol/l

0.05

205

(3020911) Cortisol [Moles/time] in 24 hour Urine

100

2.31

3.43

2.1

1.5

98.56

77.31

nmol/24h

0.75

100

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1944

18716

1.23

3.42

21.9

14.4

332.13

332.09

g/l

0.07

1935

18613

(3024928) Oxygen saturation in Venous blood

367

1.65

3.35

2.1

3.7

65.54

64.00

0.25

360

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

375

1.64

3.34

3.7

5.1

846.33

436.27

iu/ml

—

(40760888) Immunoglobulin light chains.free panel - Serum

182

1.94

3.34

3.7

4.3

—

(3035933) Granulocytes/Leukocytes in Blood

486

1.56

3.32

2.5

3.0

54.73

57.85

1.59

486

(3023419) Bacteria identified in Sputum by Culture

148

2.04

3.31

2.8

2.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.48

3.29

1.3

1.0

0.16

9.16

u/ml

0.61

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

248

1.79

3.29

1.6

1.2

4.66

6.06

umol/l

1.66

228

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.68

3.22

1.0

1.1

6.19

6.11

u/ml

0.01

(3008295) Osmolality of Serum or Plasma

178

1.92

3.19

1.3

1.7

282.23

280.32

mosm/kgh2o

0.23

146

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

258

1.76

3.18

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

631

1.48

3.14

2.2

2.9

3.25

3.52

g/l

1.48

600

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

429

1.58

3.13

1.6

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

283

1.71

3.09

3.2

4.4

0.34

0.38

iu/ml

0.48

145

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

125

2.09

3.08

1.3

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

5.01

3.05

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

160

1.95

3.04

1.3

1.2

7.16

9.13

mm/h

0.70

160

(3017354) Segmented neutrophils/Leukocytes in Blood

140

2.01

3.00

1.9

2.6

57.36

56.61

0.08

127

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

3.56

2.99

2.1

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.36

2.98

1.7

1.5

63.36

94.84

ng/l

1.87

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

435

1.56

2.97

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

264

1.72

2.96

2.0

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

201

1588

1.29

2.90

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.70

2.89

2.4

3.6

0.71

1.30

0.98

(40757494) Bilirubin.total [Moles/volume] in Blood

2.44

2.88

1.7

3.2

—

15.15

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.51

2.87

1.1

—

(3001729) Color of Synovial fluid

6.68

2.87

2.0

2.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

157

1.92

2.85

2.3

1.8

18.36

22.06

mg/l

0.28

(21494814) CD8 cells/Lymphocytes in Specimen

2.40

2.80

2.6

2.4

24.53

26.83

0.40

(4195642) Thrombophilia screening test

387

1.56

2.76

1.1

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

816

7425

1.15

2.69

2.0

2.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

105

2.11

2.68

1.1

1.0

1.24

3.91

u/ml

0.76

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

112

1504

0.73

2.68

1.4

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

327

1.60

2.67

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

108

1452

0.73

2.61

1.4

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

2.56

1.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.15

2.55

3.2

5.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.47

2.54

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

223

1.72

2.54

1.4

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.51

2.53

1.0

0.09

0.14

u/ml

—

(3002619) Bacteria identified in Specimen by Culture

2.51

2.53

1.1

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.24

2.51

1.0

0.08

0.11

u/ml

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

294

1.61

2.48

1.0

1.1

99.34

96.38

0.31

277

(3007463) Buprenorphine [Presence] in Urine

4.38

2.47

2.7

3.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

225

1.70

2.47

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

326

1.58

2.47

3.1

2.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.68

2.45

1.0

0.12

0.94

u/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.46

2.45

2.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.25

2.44

2.1

2.3

10.59

15.63

umol/l

1.71

(3005988) Vibrio sp identified in Specimen by Organism specific culture

226

1.69

2.44

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

336

1.56

2.41

1.3

1.6

—

1568.00

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

167

1.81

2.41

1.1

1.0

261.63

305.33

mg/l

2.86

153

(21494434) Karyotype in Bone marrow

2.07

2.37

1.1

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

551

1.43

2.36

2.4

6.0

1.74

1.54

0.60

518

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.65

2.36

1.0

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.62

2.36

1.1

1.2

—

(44806071) Cardiolipin IgM antibody measurement

2.83

2.34

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

396

1.50

2.32

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

170

1.77

2.28

1.0

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

134

1.88

2.26

1.1

1.5

318.36

416.37

mu/l

0.62

129

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

279

1.59

2.23

2.0

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

218

1.66

2.19

2.6

4.0

16.90

1315.45

u/ml

0.61

204

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

265

1.60

2.18

1.3

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

370

1.50

2.16

2.4

2.3

133.60

131.36

g/l

0.46

308

(3041806) Other cells [#/volume] in Blood by Manual count

189

1.70

2.13

1.8

1.5

0.58

0.49

e9/l

1.22

189

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.37

2.12

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

228

1.63

2.11

1.1

1.0

0.09

0.27

u/ml

2.67

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

405

1.47

2.11

1.2

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

198

1.68

2.09

1.3

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

183

1.70

2.08

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

131

1.84

2.08

1.6

1.3

62.29

69.32

umol/l

1.13

131

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

1.84

2.08

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

1.84

2.08

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

1.84

2.08

1.3

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.91

2.07

2.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

391

1.47

2.05

1.0

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

139

1.81

2.05

1.1

1.5

72.32

73.72

0.18

134

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1801

17429

1.14

2.04

4.2

3.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

169

1.72

2.04

1.6

1.8

0.71

1.90

u/ml

—

(40761536) Microorganisms panel - Urine sediment

222

1855

1.22

2.03

4.9

3.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

125

1.85

2.02

2.0

2.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

177

1.70

2.02

1.3

1.5

—

(3033099) Centromere Ab [Titer] in Serum

2.51

2.01

1.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

202

1.64

1.95

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

134

1.80

1.95

1.1

1.0

14.75

13.36

u/ml

0.11

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1.99

1.95

1.1

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

100

764

1.32

1.93

1.2

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

157

1.73

1.92

1.9

1.5

2.09

1.44

nmol/l

1.48

140

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

142

1138

1.26

1.91

1.9

1.7

3.97

4.26

mg/l

0.16

113

805

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

389

1.45

1.91

1.1

18.43

1408.12

iu/ml

0.56

(3051611) Lipemic interference index of Serum or Plasma

128

1.80

1.89

3.3

2.8

14.80

16.07

index

0.25

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.19

1.88

4.3

2.7

29.71

22.12

mg/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.31

1.87

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

893

8324

1.12

1.87

1.8

1.42

1.33

mmol/l

2.71

781

7339

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.65

1.86

1.0

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

107

1.88

1.86

1.2

1.1

—

(3000012) Reticulocyte production index

159

1.71

1.85

1.3

2.0

0.87

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.03

1.85

1.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.03

1.85

1.2

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.03

1.85

1.2

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.03

1.85

1.2

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.17

1.82

1.2

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

319

1.48

1.81

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.58

1.80

1.1

—

(3044927) Protein electrophoresis panel - Urine

2.01

1.80

1.3

1.2

—

(1761868) Lipid panel - Serum or Plasma

916

9755

0.90

1.74

2.7

2.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

217

0.46

1.73

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

1.2

0.00

0.07

u/ml

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

180

0.44

1.68

22.0

20.4

1474.88

1439.65

nmol/l

—

175

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1213

0.77

1.68

1.5

62.33

60.31

ug/l

0.15

1213

(3032057) Clostridioides difficile [Presence] in Stool

3.16

1.66

1.7

1.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.58

1.61

1.0

1.1

0.07

0.03

u/ml

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

698

1.30

1.61

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.91

1.59

1.0

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

516

1.35

1.59

1.6

2.1

1.25

1.38

g/l

0.62

452

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

172

0.46

1.58

20.4

15.1

792.88

8348.43

nmol/l

—

166

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.21

1.57

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.34

1.52

1.4

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.60

1.51

1.3

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

266

1.47

1.51

5.2

6.5

337.03

374.65

umol/l

1.08

241

(3008536) Aspergillus sp Ab [Presence] in Serum

2.86

1.50

1.5

2.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

243

1.49

1.47

1.1

1.0

0.25

3.06

u/ml

0.63

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

1.81

1.47

4.6

2.7

45.25

47.01

0.15

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

446

1.35

1.46

3.1

3.4

86.96

633.85

u/ml

1.02

383

(3038177) Helicobacter pylori Ab [Presence] in Serum

473

1.34

1.44

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

430

1.36

1.43

1.1

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

125

1.69

1.43

1.0

1.1

98.06

90.46

0.66

100

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.42

1.39

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

723

1.27

1.39

1.7

2.4

3.65

5.09

umol/l

2.11

542

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

120

985

1.23

1.38

1.3

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

408

1.36

1.37

1.3

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.20

1.37

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.20

1.37

1.1

1.2

1.12

1.19

mmol/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.61

1.36

1.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

163

0.49

1.35

2.4

3.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

191

1.52

1.34

1.3

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

232

1.47

1.34

1.5

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.13

1.33

1.0

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

128

1.65

1.33

1.1

—

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.04

1.32

1.5

8.91

7.93

ug/l

0.39

(3028717) Thiamine [Mass/volume] in Blood

2.10

1.30

1.0

1.4

55.44

64.70

ug/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

153

1.57

1.28

1.3

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

500

1.31

1.28

1.4

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.78

1.28

5.6

3.0

—

(3017569) Oxygen content in Arterial blood

2.00

1.27

1.5

3.1

16.57

17.03

0.19

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.79

1.27

1.2

—

62.86

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

422

0.68

1.24

4.2

3.8

23.67

26.08

u/ml

0.13

408

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.40

1.24

2.0

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.40

1.24

1.2

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.40

1.24

1.0

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.23

1.24

3.3

4.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

237

1.44

1.22

1.2

1.4

—

(3022689) Creatine [Moles/volume] in Urine

2.05

1.22

1.4

1.3

8.81

8.00

mmol/l

—

(3017509) Phencyclidine [Presence] in Urine

2.17

1.21

1.8

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.93

1.17

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

352

1.34

1.14

1.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

488

5264

0.91

1.13

1.7

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.90

1.12

1.1

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

177

1.47

1.07

1.8

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.87

1.07

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.87

1.07

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

137

1.54

1.05

1.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.12

1.05

1.0

5.22

7.17

u/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.12

1.05

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

129

1.56

1.05

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.80

1.04

1.4

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

1375

0.84

1.03

1.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.28

1.03

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.28

1.03

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

382

0.70

1.03

2.1

2.7

—

31.59

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.84

1.02

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

248

1.38

0.99

1.1

9.51

15.13

u/ml

—

121

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.18

0.98

1.6

1.9

—

(3044009) aPTT.lupus sensitive (LA screen)

2.18

0.98

1.2

—

(3019174) dRVVT (LA screen)

2.18

0.98

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

434

0.73

0.96

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

346

1.31

0.95

2.8

3.3

23.75

22.00

mg/l

0.14

236

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.72

0.92

1.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

874

0.82

0.92

1.2

1.3

—

(4035726) Immunohistochemistry procedure

167

1473

1.14

0.91

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.07

0.89

2.2

2.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.79

0.87

1.0

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.79

0.87

1.0

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.67

0.85

1.0

1.3

—

(3004451) EKG impression Narrative

1.76

0.83

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

171

1.41

0.83

1.9

1.7

1.87

1.34

promille

0.96

132

(3003694) ABO and Rh group [Type] in Blood

786

7518

1.07

0.81

1.6

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

114

1.49

0.79

1.1

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.77

0.0

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

191

1.37

0.77

1.1

1868.12

1492.06

miu/ml

0.80

191

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

148

1315

1.13

0.76

3.2

4.0

3.25

39.00

ug/l

0.72

114

959

(3032773) Endomysium IgG Ab [Titer] in Serum

288

1.29

0.75

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

0.74

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.09

0.74

1.0

1.1

—

12.17

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.09

0.74

1.0

1.1

—

24.83

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.67

0.74

1.3

3.4

2.39

1.88

ratio

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.00

0.72

1.0

1.2

1.34

1.62

umol/24h

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

109

1.47

0.71

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

410

0.78

0.70

2.1

2.4

0.90

0.69

ug/l

0.22

193

(21494890) Protein electrophoresis panel - 24 hour Urine

101

1.49

0.70

2.3

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.53

0.68

1.2

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

161

1.37

0.68

2.1

2.6

0.48

1.34

g/24h

—

107

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.63

0.66

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

285

1.27

0.66

1.4

1.5

7.28

7.47

mmol/l

0.11

280

(3014271) Vancomycin [Susceptibility]

1.79

0.66

2.0

2.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

648

6203

1.06

0.65

1.7

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

242

1.28

0.64

1.5

1.6

—

(1002224) Polysomnography panel

143

1288

1.12

0.62

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.67

0.61

4.6

6.0

0.06

0.18

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.46

0.61

1.5

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

192

1.31

0.59

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

0.00

0.58

0.0

1.5

—

(40768793) Breast Pathology biopsy report

689

0.85

0.56

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

286

0.77

0.56

1.6

2.7

26.39

104.47

ug/min

1.95

186

(3037756) Immunofixation for Serum or Plasma

185

1.30

0.56

1.5

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.45

0.55

1.8

1.5

0.88

5.50

u/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

449

1.18

0.55

1.4

1.5

—

(3034426) Prothrombin time (PT)

1.47

0.54

1.2

28.67

28.37

0.06

(3017704) Immunofixation for Urine

1.58

0.54

1.8

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.50

0.54

1.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.50

0.54

1.2

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.54

0.53

1.0

1.3

—

7.29

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.45

0.53

1.1

2.4

—

51151.00

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

761

1.14

0.52

1.1

0.82

5.37

eliau/ml

—

134

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.43

0.52

1.1

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.43

0.52

1.1

1.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.61

0.52

1.5

1.6

36.48

36.69

g/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

186

1720

1.09

0.51

6.2

4.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

119

1.35

0.48

1.4

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

0.61

0.45

1.2

1.4

—

119067.16

—

(3020650) Glucose [Presence] in Urine

0.59

0.45

1.6

0.00

estimate

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

417

4356

0.95

0.44

1.7

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

284

1.20

0.43

2.4

4.8

18.04

118.00

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.41

0.43

1.0

13.62

38.42

iu/ml

2.67

(4281824) Cell count and differential, peritoneal fluid

240

0.79

0.42

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

674

6538

1.04

0.41

1.7

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

138

0.72

0.40

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.40

0.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.37

0.40

1.6

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

531

1.13

0.39

1.4

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.43

0.39

1.0

1.4

183.80

366.85

pmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

124

1.29

0.38

1.1

—

(3047181) Lactate [Moles/volume] in Blood

411

1.15

0.37

2.5

7.2

1.15

1.19

mmol/l

0.15

358

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

699

1.11

0.35

4.4

3.6

1.73

1.86

ug/l

0.06

637

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

186

1971

0.94

0.34

4.3

3.8

31.33

32.61

0.93

145

1441

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.36

0.34

1.5

2.3

39.80

41.87

g/l

—

(4133840) Spirometry

1.33

0.33

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.71

0.30

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.30

0.30

2.4

1.9

—

139.83

—

(4146454) Self-monitoring of blood glucose

111

1.26

0.30

2.0

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.32

0.28

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.28

0.28

1.6

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.25

0.27

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.27

3.4

2.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

120

0.75

0.27

1.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

189

1981

0.95

0.26

1.8

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.21

0.26

1.1

2.8

7.83

8.00

mmol/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.71

0.24

1.3

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

39.51

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.21

0.0

3.7

—

6.73

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

182

1.16

0.21

1.0

1.1

—

(4211845) Urine protein measurement

102

0.78

0.21

1.4

2.5

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

72.30

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.21

0.0

1.1

—

34.25

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.08

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.20

0.0

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.25

0.20

3.8

2.9

0.60

0.62

mmol/l

—

(3047189) Immunofixation for 24 hour Urine

1.23

0.20

2.5

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

115

0.78

0.20

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

623

0.93

0.19

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

155

1488

1.04

0.19

1.4

1.3

168.52

238.50

miu/ml

1.78

780

(3003740) Influenza virus B Ag [Presence] in Specimen

622

0.93

0.18

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

120

1.17

0.16

1.5

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

535

0.93

0.16

4.2

3.4

21.72

22.78

0.23

185

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.82

0.13

4.5

2.4

97.63

156.92

nmol/l

—

(3025130) Human papilloma virus identified in Specimen

715

1.05

0.13

1.7

1.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

866

0.96

0.13

1.3

1.4

2.53

3.81

ug/l

2.35

809

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

293

0.92

0.12

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

134

1.12

0.11

1.0

1.1

—

(44806420) Estimation of glomerular filtration rate

339

1.06

0.10

1.9

2.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

457

1.05

0.09

1.1

1.02

3.11

eliau/ml

2.58

251

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.11

0.09

1.0

1.1

1.89

1.24

mom

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.09

1.2

4.9

4.21

4.66

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.09

1.2

4.9

12.78

11.39

kpa

—

(3001556) Androgen free Index in Serum or Plasma

1.11

0.09

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.06

0.09

1.2

1.1

—

(40768441) Liver Pathology biopsy report

145

1.10

0.09

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.11

0.09

1.3

89.65

150.09

pmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.08

0.07

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

192

0.94

0.05

1.5

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

445

0.97

0.05

1.5

1.6

7.30

7.59

mmol/l

0.59

430

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

318

3151

1.01

0.05

1.9

2.0

—

(3042631) Mycobacterium sp identified in Specimen

130

1.08

0.04

2.6

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

200

0.95

0.03

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

159

0.94

0.03

1.6

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

728

0.99

0.01

1.7

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

215

0.98

0.00

1.1

1.2

—

1.46

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

184

0.98

0.00

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

226

1.02

0.00

1.3

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

226

1.02

0.00

1.3

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

226

1.02

0.00

1.3

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

226

1.02

0.00

1.3

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

496

1.01

0.00

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

182

0.99

0.00

1.4

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

107

1.03

0.00

1.0

1.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.0

1.6

—

3500.80

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

3.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

4.43

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

156.33

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.94

-0.00

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.89

-0.00

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.1

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.8

—

7.82

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.89

-0.00

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

25.42

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

34.55

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.91

-0.00

1.3

1.2

87.78

61.98

ug/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

8.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

0.00

-0.00

0.0

1.3

—

74.07

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.97

-0.00

1.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

3.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

6.8

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.7

—

(3006462) Nitrate [Presence] in Urine

0.91

-0.00

1.4

2.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.89

-0.00

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

2.20

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.1

—

404.25

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_HYPERMOBILITY and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_HYPERMOBILITY	0.823 [0.69, 0.99]	0.036
Birth year	0.995 [0.99, 1.0]	0.279

During the follow-up period (1.1.1998 — 31.12.2019), 192 out of 10095 females with M13_HYPERMOBILITY died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_HYPERMOBILITY.

N-year risk	Females	Males
1	0.072%	No data
5	0.416%	No data
10	1.087%	No data
15	2.289%	No data
20	4.021%	No data

Relationships between endpoints

↥

Index endpoint: M13_HYPERMOBILITY – Hypermobility syndrome

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypermobility syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints